Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1'S,5'S)-averufin biosynthesis
-
-
PWY-5954
(1,4)-beta-D-xylan degradation
-
-
PWY-6717
(3R)-linalool biosynthesis
-
-
PWY-7709
(3R)-N-[(2S)-1-hydroxy-6-[(3R)-3-isocyanobutanamido]hexan-2-yl]-3-isocyanobutanamide biosynthesis
-
-
PWY-8320
(3S)-linalool biosynthesis
-
-
PWY-7141
(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)
-
-
PWY-7728
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)
-
-
PWY-7726
(5R)-carbapenem carboxylate biosynthesis
(5Z)-dodecenoate biosynthesis I
-
-
PWY0-862
(5Z)-dodecenoate biosynthesis II
-
-
PWY-7858
(8E,10E)-dodeca-8,10-dienol biosynthesis
-
-
PWY-7654
(9Z)-tricosene biosynthesis
-
-
PWY-7035
(aminomethyl)phosphonate degradation
-
-
PWY-7805
(Kdo)2-lipid A biosynthesis (E. coli)
-
-
KDO-LIPASYN-PWY
(Kdo)2-lipid A biosynthesis (generic)
-
-
PWY-8285
(Kdo)2-lipid A biosynthesis (H. pylori)
-
-
PWY2DNV-2
(Kdo)2-lipid A biosynthesis (P. gingivalis)
-
-
PWY-8247
(Kdo)2-lipid A biosynthesis (P. putida)
-
-
PWY-8075
(Kdo)2-lipid A biosynthesis I (Brucella)
-
-
PWY2B4Q-7
(Kdo)2-lipid A modification (H. pylori)
-
-
PWY2DNV-3
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7216
(R)-camphor degradation
-
-
P601-PWY
(R)-cysteate degradation
-
-
PWY-6642
(S)-camphor degradation
-
-
PWY-6989
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
(S)-propane-1,2-diol degradation
-
-
PWY-7013
(S)-reticuline biosynthesis
-
-
(S)-reticuline biosynthesis I
-
-
PWY-3581
(S)-reticuline biosynthesis II
-
-
PWY-6133
1,2-dichloroethane degradation
-
-
12DICHLORETHDEG-PWY
1,2-propanediol biosynthesis from lactate (engineered)
-
-
PWY-7541
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,5-anhydrofructose degradation
-
-
PWY-6992
1-butanol autotrophic biosynthesis (engineered)
-
-
PWY-6886
1-methylpyrrolinium biosynthesis
-
-
PWY-5315
10-cis-heptadecenoyl-CoA degradation (yeast)
-
-
PWY-7337
10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast)
-
-
PWY-7339
10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)
-
-
PWY-7338
11-oxyandrogens biosynthesis
-
-
PWY-8202
15-epi-lipoxin biosynthesis
-
-
PWY66-393
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3)
-
-
PWY-6361
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)
-
-
PWY-6362
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza)
-
-
PWY-4661
1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium)
-
-
PWY-6372
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)
-
-
PWY-6554
2'-deoxymugineic acid phytosiderophore biosynthesis
-
-
PWY-5912
2,3-dihydroxybenzoate biosynthesis
-
-
PWY-5901
2-amino-3-carboxymuconate semialdehyde degradation to 2-hydroxypentadienoate
-
-
PWY-5654
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA
-
-
PWY-5652
2-amino-3-hydroxycyclopent-2-enone biosynthesis
-
-
PWY-7536
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
2-carboxy-1,4-naphthoquinol biosynthesis
-
-
PWY-5837
2-deoxy-alpha-D-ribose 1-phosphate degradation
-
-
PWY-7180
2-deoxy-D-glucose 6-phosphate degradation
-
-
PWY-8121
2-deoxy-D-ribose degradation I
-
-
PWY-8060
2-deoxy-D-ribose degradation II
-
-
PWY-8058
2-methyl-branched fatty acid beta-oxidation
-
-
PWY-8181
2-methylpropene degradation
-
-
PWY-7778
2-nitrobenzoate degradation I
-
-
PWY-5647
2-nitrotoluene degradation
-
-
PWY-5641
2-oxobutanoate degradation II
-
-
2OXOBUTYRATECAT-PWY
2-oxoglutarate decarboxylation to succinyl-CoA
-
-
PWY-5084
2-oxoisovalerate decarboxylation to isobutanoyl-CoA
-
-
PWY-5046
24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)
-
-
PWY-8238
3,5-dimethoxytoluene biosynthesis
-
-
PWY-7076
3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)
-
-
CHLOROPHYLL-SYN
3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic)
-
-
PWY-5531
3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent)
-
-
PWY-7159
3-(4-hydroxyphenyl)pyruvate biosynthesis
-
-
PWY-5886
3-chlorocatechol degradation
-
-
3-dehydroquinate biosynthesis II (archaea)
-
-
PWY-6160
3-hydroxy-4-methyl-anthranilate biosynthesis I
-
-
PWY-7717
3-hydroxy-4-methyl-anthranilate biosynthesis II
-
-
PWY-7765
3-hydroxypropanoate cycle
-
-
PWY-5743
3-hydroxypropanoate/4-hydroxybutanate cycle
-
-
PWY-5789
3-hydroxyquinaldate biosynthesis
-
-
PWY-7733
3-methyl-branched fatty acid alpha-oxidation
-
-
PWY66-387
3-methylbutanol biosynthesis (engineered)
-
-
PWY-6871
3-oxoadipate degradation
-
-
PWY-2361
3-phenylpropanoate degradation
-
-
P281-PWY
3-phenylpropionate degradation
-
-
3-phosphoinositide biosynthesis
-
-
PWY-6352
3-phosphoinositide degradation
-
-
PWY-6368
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis II
-
-
PWY-7282
4-aminobenzoate biosynthesis I
-
-
PWY-6543
4-aminobenzoate biosynthesis II
-
-
PWY-8276
4-aminobutanoate degradation I
-
-
PWY-6535
4-aminobutanoate degradation II
-
-
PWY-6537
4-aminobutanoate degradation III
-
-
PWY-6536
4-aminobutanoate degradation IV
-
-
PWY-6473
4-aminobutanoate degradation V
-
-
PWY-5022
4-chlorobenzoate degradation
-
-
PWY-6215
4-coumarate degradation (aerobic)
-
-
PWY-8002
4-ethylphenol degradation (anaerobic)
-
-
PWY-6080
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
4-hydroxy-3-prenylbenzoate biosynthesis
-
-
PWY-7303
4-hydroxybenzoate biosynthesis I (eukaryotes)
-
-
PWY-5754
4-hydroxybenzoate biosynthesis III (plants)
-
-
PWY-6435
4-hydroxymandelate degradation
4-hydroxyphenylacetate degradation
4-methylcatechol degradation (ortho cleavage)
-
-
PWY-6185
4-methylphenol degradation to protocatechuate
-
-
PWY-7700
4-nitrophenol degradation I
-
-
PWY-5487
4-nitrophenol degradation II
-
-
PWY-5488
4-oxopentanoate degradation
-
-
PWY-7948
5'-deoxyadenosine degradation I
-
-
PWY-8130
5,6-dimethylbenzimidazole biosynthesis I (aerobic)
-
-
PWY-5523
5-aminoimidazole ribonucleotide biosynthesis I
-
-
PWY-6121
5-aminoimidazole ribonucleotide biosynthesis II
-
-
PWY-6122
5-oxo-L-proline metabolism
-
-
PWY-7942
6-gingerol analog biosynthesis (engineered)
-
-
PWY-6920
6-hydroxymethyl-dihydropterin diphosphate biosynthesis
-
-
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I
-
-
PWY-6147
6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium)
-
-
PWY-7852
8-amino-7-oxononanoate biosynthesis I
-
-
PWY-6519
8-amino-7-oxononanoate biosynthesis IV
-
-
PWY-8203
9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)
-
-
PWY-7340
9-lipoxygenase and 9-allene oxide synthase pathway
-
-
PWY-5407
9-lipoxygenase and 9-hydroperoxide lyase pathway
-
-
PWY-5408
ABH and Lewis epitopes biosynthesis from type 1 precursor disaccharide
-
-
PWY-7832
ABH and Lewis epitopes biosynthesis from type 2 precursor disaccharide
-
-
PWY-7831
abscisic acid biosynthesis
-
-
PWY-695
Ac/N-end rule pathway
-
-
PWY-7800
acetaldehyde biosynthesis I
-
-
PWY-6333
acetaldehyde biosynthesis II
-
-
PWY-6330
acetate and ATP formation from acetyl-CoA I
-
-
PWY0-1312
acetate and ATP formation from acetyl-CoA III
-
-
PWY-8328
acetate conversion to acetyl-CoA
-
-
PWY0-1313
acetoacetate degradation (to acetyl CoA)
-
-
ACETOACETATE-DEG-PWY
acetone degradation I (to methylglyoxal)
-
-
PWY-5451
acetone degradation III (to propane-1,2-diol)
-
-
PWY-7466
acetyl CoA biosynthesis
-
-
acetyl-CoA biosynthesis from citrate
-
-
PWY-5172
acetyl-CoA fermentation to butanoate
-
-
PWY-5676
acetylene degradation (anaerobic)
-
-
P161-PWY
acrylate degradation I
-
-
PWY-6373
acrylonitrile degradation I
-
-
PWY-7308
acyl carrier protein activation
-
-
PWY-6012-1
acyl carrier protein metabolism
-
-
PWY-6012
acyl-CoA hydrolysis
-
-
PWY-5148
adenine and adenosine salvage I
-
-
P121-PWY
adenine and adenosine salvage III
-
-
PWY-6609
adenine and adenosine salvage V
-
-
PWY-6611
adenine and adenosine salvage VI
-
-
PWY-6619
adenine salvage
-
-
PWY-6610
adenosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7227
adenosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7220
adenosine nucleotides degradation I
-
-
PWY-6596
adenosine nucleotides degradation II
-
-
SALVADEHYPOX-PWY
adenosine ribonucleotides de novo biosynthesis
-
-
PWY-7219
adenosylcobinamide-GDP biosynthesis from cobyrinate a,c-diamide
-
-
PWY-7962
adenosylcobinamide-GDP salvage from assorted adenosylcobamides
-
-
PWY-8282
adenosylcobinamide-GDP salvage from cobinamide I
-
-
PWY-7971
adenosylcobinamide-GDP salvage from cobinamide II
-
-
PWY-7972
adipate biosynthesis
-
-
PWY-8347
adlupulone and adhumulone biosynthesis
-
-
PWY-7857
ADP-L-glycero-beta-D-manno-heptose biosynthesis
-
-
PWY0-1241
aerobic respiration I (cytochrome c)
-
-
PWY-3781
aerobic respiration II (cytochrome c) (yeast)
-
-
PWY-7279
aerobic respiration III (alternative oxidase pathway)
-
-
PWY-4302
aerobic toluene degradation
-
-
Aflatoxin biosynthesis
-
-
aflatoxin biosynthesis
-
-
Alanine, aspartate and glutamate metabolism
-
-
alginate degradation
-
-
PWY-6986
alkane biosynthesis II
-
-
PWY-7033
alkane oxidation
-
-
PWY-2724
all-trans-decaprenyl diphosphate biosynthesis
-
-
PWY-5806
all-trans-farnesol biosynthesis
-
-
PWY-6859
allantoin degradation
-
-
alliin metabolism
-
-
PWY-5706
allopregnanolone biosynthesis
-
-
PWY-7455
alpha-amyrin biosynthesis
-
-
PWY-5377
alpha-linolenate biosynthesis I (plants and red algae)
-
-
PWY-5997
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
alpha-Linolenic acid metabolism
-
-
alpha-tocopherol degradation
-
-
PWY-6377
alpha-tomatine degradation
-
-
PWY18C3-5
Amaryllidacea alkaloids biosynthesis
-
-
PWY-7826
Amino sugar and nucleotide sugar metabolism
-
-
Aminoacyl-tRNA biosynthesis
-
-
Aminobenzoate degradation
-
-
aminopropanol phosphate biosynthesis II
-
-
PWY-7378
ammonia assimilation cycle I
-
-
PWY-6963
ammonia assimilation cycle II
-
-
PWY-6964
ammonia assimilation cycle III
-
-
AMMASSIM-PWY
ammonia oxidation I (aerobic)
-
-
AMMOXID-PWY
ammonia oxidation II (anaerobic)
-
-
P303-PWY
ammonia oxidation III
-
-
PWY-2242
amygdalin and prunasin degradation
-
-
PWY-6011
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anaerobic energy metabolism (invertebrates, mitochondrial)
-
-
PWY-7384
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anandamide degradation
-
-
PWY6666-1
anandamide lipoxygenation
-
-
PWY-8056
anapleurotic synthesis of oxalacetate
-
-
androgen and estrogen metabolism
-
-
androgen biosynthesis
-
-
PWY66-378
androstenedione degradation I (aerobic)
-
-
PWY-6944
androstenedione degradation II (anaerobic)
-
-
PWY-8152
anteiso-branched-chain fatty acid biosynthesis
-
-
PWY-8173
apratoxin A biosynthesis
-
-
PWY-8361
Arabinogalactan biosynthesis - Mycobacterium
-
-
arachidonate biosynthesis
-
-
arachidonate biosynthesis I (6-desaturase, lower eukaryotes)
-
-
PWY-5353
arachidonate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7592
arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)
-
-
PWY-7601
arachidonate biosynthesis V (8-detaturase, mammals)
-
-
PWY-7725
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arachidonic acid metabolism
-
-
arachidonic acid metabolism
-
-
Arg/N-end rule pathway (eukaryotic)
-
-
PWY-7799
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
aromatic glucosinolate activation
-
-
PWY-6684
aromatic biogenic amine degradation (bacteria)
-
-
PWY-7431
aromatic polyketides biosynthesis
-
-
PWY-6316
arsenate detoxification I
-
-
PWY-8264
arsenate detoxification V
-
-
PWY1YI0-1
arsenic detoxification (mammals)
-
-
PWY-4202
arsenic detoxification (plants)
-
-
PWY-8259
arsenic detoxification (yeast)
-
-
PWY-4621
arsenite to oxygen electron transfer
-
-
PWY-4521
arsenite to oxygen electron transfer (via azurin)
-
-
PWY-7429
Ascorbate and aldarate metabolism
-
-
ascorbate glutathione cycle
-
-
PWY-2261
ascorbate recycling (cytosolic)
-
-
PWY-6370
aspartate and asparagine metabolism
-
-
aspirin triggered resolvin D biosynthesis
-
-
PWY66-395
aspirin triggered resolvin E biosynthesis
-
-
PWY66-394
assimilatory sulfate reduction II
-
-
SULFMETII-PWY
assimilatory sulfate reduction III
-
-
PWY-6683
assimilatory sulfate reduction IV
-
-
PWY1ZNC-1
astaxanthin biosynthesis (bacteria, fungi, algae)
-
-
PWY-5288
ATP biosynthesis
-
-
PWY-7980
atromentin biosynthesis
-
-
PWY-7518
autoinducer AI-2 biosynthesis I
-
-
PWY-6153
autoinducer AI-2 biosynthesis II (Vibrio)
-
-
PWY-6154
avenanthramide biosynthesis
-
-
PWY-8157
backdoor pathway of androgen biosynthesis
-
-
PWY-8200
bacterial bioluminescence
-
-
PWY-7723
baicalein degradation (hydrogen peroxide detoxification)
-
-
PWY-7214
benzoate biosynthesis I (CoA-dependent, beta-oxidative)
-
-
PWY-6443
benzoate biosynthesis III (CoA-dependent, non-beta-oxidative)
-
-
PWY-6446
benzoyl-CoA biosynthesis
-
-
PWY-6458
benzoyl-CoA degradation
-
-
benzoyl-CoA degradation I (aerobic)
-
-
PWY-1361
beta-(1,4)-mannan degradation
-
-
PWY-7456
beta-1,4-D-mannosyl-N-acetyl-D-glucosamine degradation
-
-
PWY-7586
beta-alanine biosynthesis I
-
-
PWY-3981
beta-alanine biosynthesis II
-
-
PWY-3941
beta-alanine biosynthesis IV
-
-
PWY-5760
beta-alanine degradation I
-
-
BETA-ALA-DEGRADATION-I-PWY
beta-alanine degradation II
-
-
PWY-1781
beta-Alanine metabolism
-
-
beta-carboline biosynthesis
-
-
PWY-5877
beta-D-glucuronide and D-glucuronate degradation
-
-
PWY-7247
Betalain biosynthesis
-
-
betalamic acid biosynthesis
-
-
PWY-5394
betanidin degradation
-
-
PWY-5461
betaxanthin biosynthesis
-
-
PWY-5426
betaxanthin biosynthesis (via dopamine)
-
-
PWY-5403
Bifidobacterium shunt
-
-
P124-PWY
bile acid 7alpha-dehydroxylation
-
-
PWY-7754
bile acid 7beta-dehydroxylation
-
-
PWY-8134
bile acid biosynthesis, neutral pathway
bile acids deconjugation
-
-
PWY-8135
Biosynthesis of 12-, 14- and 16-membered macrolides
-
-
Biosynthesis of ansamycins
-
-
biosynthesis of Lewis epitopes (H. pylori)
-
-
PWY-7833
Biosynthesis of secondary metabolites
-
-
Biosynthesis of siderophore group nonribosomal peptides
-
-
Biosynthesis of type II polyketide backbone
-
-
Biosynthesis of unsaturated fatty acids
-
-
Biosynthesis of various secondary metabolites - part 3
-
-
biotin-carboxyl carrier protein assembly
-
-
PWY0-1264
bis(guanylyl molybdopterin) cofactor sulfurylation
-
-
PWY-8164
bisabolene biosynthesis (engineered)
-
-
PWY-7102
bisphenol A degradation
-
-
PWY-7757
Bisphenol degradation
-
-
brassicicene C biosynthesis
-
-
PWY-7517
brassinolide biosynthesis I
-
-
PWY-699
brassinolide biosynthesis II
-
-
PWY-2582
Brassinosteroid biosynthesis
-
-
bryostatin biosynthesis
-
-
PWY-8047
bupropion degradation
-
-
PWY66-241
butanoate fermentation
-
-
butanol and isobutanol biosynthesis (engineered)
-
-
PWY-7396
C20 prostanoid biosynthesis
-
-
PWY66-374
C25,25 CDP-archaeol biosynthesis
-
-
PWY-8365
C4 and CAM-carbon fixation
-
-
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
C4 photosynthetic carbon assimilation cycle, NADP-ME type
-
-
PWY-241
C4 photosynthetic carbon assimilation cycle, PEPCK type
-
-
PWY-7117
C5-Branched dibasic acid metabolism
-
-
caffeine biosynthesis I
-
-
PWY-5037
caffeine biosynthesis II (via paraxanthine)
-
-
PWY-5038
caffeine degradation III (bacteria, via demethylation)
-
-
PWY-6538
Calvin-Benson-Bassham cycle
-
-
CALVIN-PWY
camalexin biosynthesis
-
-
CAMALEXIN-SYN
canavanine biosynthesis
-
-
PWY-5
canavanine degradation
-
-
PWY-31
cannabinoid biosynthesis
-
-
PWY-5140
Caprolactam degradation
-
-
capsaicin biosynthesis
-
-
PWY-5710
Carbapenem biosynthesis
-
-
Carbon fixation in photosynthetic organisms
-
-
Carbon fixation pathways in prokaryotes
-
-
cardiolipin biosynthesis
-
-
cardiolipin biosynthesis I
-
-
PWY-5668
cardiolipin biosynthesis II
-
-
PWY-5269
cardiolipin biosynthesis III
-
-
PWY0-1545
carnosine biosynthesis
-
-
PWY66-420
Carotenoid biosynthesis
-
-
carotenoid biosynthesis
-
-
catechol degradation to 2-hydroxypentadienoate I
-
-
P183-PWY
catechol degradation to 2-hydroxypentadienoate II
-
-
PWY-5419
catechol degradation to beta-ketoadipate
-
-
CATECHOL-ORTHO-CLEAVAGE-PWY
catecholamine biosynthesis
CDP-6-deoxy-D-gulose biosynthesis
-
-
PWY-8139
CDP-diacylglycerol biosynthesis
-
-
CDP-diacylglycerol biosynthesis I
-
-
PWY-5667
CDP-diacylglycerol biosynthesis II
-
-
PWY0-1319
CDP-diacylglycerol biosynthesis III
-
-
PWY-5981
cell-surface glycoconjugate-linked phosphocholine biosynthesis
-
-
PWY-7886
cellulose and hemicellulose degradation (cellulolosome)
-
-
PWY-6784
cellulose degradation
-
-
cellulose degradation II (fungi)
-
-
PWY-6788
ceramide and sphingolipid recycling and degradation (yeast)
-
-
PWY-7119
ceramide biosynthesis
-
-
ceramide de novo biosynthesis
-
-
PWY3DJ-12
ceramide degradation (generic)
-
-
PWY-6483
ceramide degradation by alpha-oxidation
-
-
PWY66-388
chitin biosynthesis
-
-
PWY-6981
chitin deacetylation
-
-
PWY-7118
chitin degradation I (archaea)
-
-
PWY-6855
chitin degradation II (Vibrio)
-
-
PWY-6902
chitin degradation III (Serratia)
-
-
PWY-7822
chitin derivatives degradation
-
-
PWY-6906
Chloroalkane and chloroalkene degradation
-
-
Chlorocyclohexane and chlorobenzene degradation
-
-
chlorogenic acid biosynthesis I
-
-
PWY-6039
chlorogenic acid degradation
-
-
PWY-6781
chlorophyll metabolism
-
-
chlorpyrifos degradation
-
-
PWY-8065
cholesterol biosynthesis
-
-
cholesterol biosynthesis (algae, late side-chain reductase)
-
-
PWY-8191
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis I
-
-
PWY66-341
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
cholesterol biosynthesis III (via desmosterol)
-
-
PWY66-4
cholesterol degradation to androstenedione I (cholesterol oxidase)
-
-
PWY-6945
cholesterol degradation to androstenedione II (cholesterol dehydrogenase)
-
-
PWY-6946
cholesterol degradation to androstenedione III (anaerobic)
-
-
PWY-8151
choline biosynthesis III
-
-
PWY-3561
choline degradation I
-
-
CHOLINE-BETAINE-ANA-PWY
choline degradation IV
-
-
PWY-7494
chondroitin sulfate biosynthesis
-
-
PWY-6567
chondroitin sulfate degradation I (bacterial)
-
-
PWY-6572
chorismate biosynthesis from 3-dehydroquinate
-
-
PWY-6163
chorismate metabolism
-
-
cichoriin interconversion
-
-
PWY-7057
cis-geranyl-CoA degradation
-
-
PWY-6672
cis-vaccenate biosynthesis
cis-zeatin biosynthesis
-
-
PWY-2781
Citrate cycle (TCA cycle)
-
-
CMP phosphorylation
-
-
PWY-7205
CMP-3-deoxy-D-manno-octulosonate biosynthesis
-
-
PWY-1269
CMP-diacetamido-8-epilegionaminic acid biosynthesis
-
-
PWY-7719
CMP-legionaminate biosynthesis I
-
-
PWY-6749
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)
-
-
PWY-6138
CMP-N-acetylneuraminate biosynthesis II (bacteria)
-
-
PWY-6139
CMP-N-glycoloylneuraminate biosynthesis
-
-
PWY-6144
CMP-pseudaminate biosynthesis
-
-
PWY-6143
CO2 fixation in Crenarchaeota
-
-
CO2 fixation into oxaloacetate (anaplerotic)
-
-
PWYQT-4429
cob(II)yrinate a,c-diamide biosynthesis II (late cobalt incorporation)
-
-
PWY-7376
coenzyme A biosynthesis I (bacteria)
-
-
COA-PWY
coenzyme A biosynthesis II (eukaryotic)
-
-
PWY-7851
coenzyme A biosynthesis III (archaea)
-
-
PWY-8342
coenzyme A metabolism
-
-
coenzyme B biosynthesis
-
-
P241-PWY
coenzyme M biosynthesis
-
-
coenzyme M biosynthesis II
-
-
PWY-6643
colanic acid building blocks biosynthesis
-
-
COLANSYN-PWY
colupulone and cohumulone biosynthesis
-
-
PWY-5133
complex N-linked glycan biosynthesis (plants)
-
-
PWY-7920
complex N-linked glycan biosynthesis (vertebrates)
-
-
PWY-7426
conversion of succinate to propanoate
-
-
PWY0-43
coumarin biosynthesis (via 2-coumarate)
-
-
PWY-5176
coumarins biosynthesis (engineered)
-
-
PWY-7398
creatine biosynthesis
-
-
GLYCGREAT-PWY
creatine phosphate biosynthesis
-
-
PWY-6158
creatinine degradation
-
-
creatinine degradation I
-
-
CRNFORCAT-PWY
creatinine degradation II
-
-
PWY-4722
cremeomycin biosynthesis
-
-
PWY-8296
crotonate fermentation (to acetate and cyclohexane carboxylate)
-
-
PWY-7401
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered)
-
-
PWY-7854
curacin A biosynthesis
-
-
PWY-8358
curcuminoid biosynthesis
-
-
PWY-6432
cuticular wax biosynthesis
-
-
PWY-282
cutin biosynthesis
-
-
PWY-321
Cutin, suberine and wax biosynthesis
-
-
cyanide detoxification II
-
-
PWY-7142
Cyanoamino acid metabolism
-
-
cyanophycin metabolism
-
-
PWY-7052
cyclic electron flow
-
-
PWY-8270
cylindrospermopsin biosynthesis
-
-
PWY-8045
Cysteine and methionine metabolism
-
-
cytidylyl molybdenum cofactor sulfurylation
-
-
PWY-8165
cytosolic NADPH production (yeast)
-
-
PWY-7268
D-Amino acid metabolism
-
-
D-arabinitol degradation I
-
-
DARABITOLUTIL-PWY
D-arabinose degradation V
-
-
PWY-8334
D-cycloserine biosynthesis
-
-
PWY-7274
D-galactose degradation I (Leloir pathway)
-
-
PWY-6317
D-galactose degradation II
-
-
GALDEG-PWY
D-galactose degradation IV
-
-
PWY-6693
D-galactose detoxification
-
-
PWY-3821
D-gluconate degradation
-
-
GLUCONSUPER-PWY
D-glucuronate degradation I
-
-
PWY-5525
d-mannose degradation
-
-
D-mannose degradation I
-
-
MANNCAT-PWY
D-mannose degradation II
-
-
PWY3O-1743
D-myo-inositol (1,3,4)-trisphosphate biosynthesis
-
-
PWY-6364
D-myo-inositol (1,4,5)-trisphosphate biosynthesis
-
-
PWY-6351
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6366
D-myo-inositol-5-phosphate metabolism
-
-
PWY-6367
D-sorbitol biosynthesis I
-
-
PWY-5054
D-sorbitol degradation I
-
-
PWY-4101
D-xylose degradation I
-
-
XYLCAT-PWY
D-xylose degradation to ethylene glycol (engineered)
-
-
PWY-7178
D-xylose degradation V
-
-
PWY-8020
daidzein conjugates interconversion
-
-
PWY-2343
daidzin and daidzein degradation
-
-
PWY-6996
daphnin interconversion
-
-
PWY-7056
degradation of aromatic, nitrogen containing compounds
-
-
degradation of hexoses
-
-
degradation of pentoses
-
-
degradation of sugar acids
-
-
degradation of sugar alcohols
-
-
dehydro-D-arabinono-1,4-lactone biosynthesis
-
-
PWY3O-6
dermatan sulfate biosynthesis
-
-
PWY-6568
dermatan sulfate degradation I (bacterial)
-
-
PWY-7646
detoxification of reactive carbonyls in chloroplasts
-
-
PWY-6786
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
di-myo-inositol phosphate biosynthesis
-
-
PWY-6664
di-trans,poly-cis-undecaprenyl phosphate biosynthesis
-
-
PWY-5785
diacylglycerol and triacylglycerol biosynthesis
-
-
TRIGLSYN-PWY
diacylglycerol biosynthesis (PUFA enrichment in oilseed)
-
-
PWY-6804
diethylphosphate degradation
-
-
PWY-5491
digitoxigenin biosynthesis
-
-
PWY-6032
dimethyl sulfide biosynthesis from methionine
-
-
PWY-7793
dimethylsulfoniopropanoate biosynthesis I (Wollastonia)
-
-
PWY-6054
dimethylsulfoniopropanoate biosynthesis II (Spartina)
-
-
PWY-6055
dimorphecolate biosynthesis
-
-
PWY-5368
dipicolinate biosynthesis
-
-
PWY-8088
diploterol biosynthesis
-
-
PWY-6098
dissimilatory sulfate reduction I (to hydrogen sufide))
-
-
DISSULFRED-PWY
Diterpenoid biosynthesis
-
-
divinyl ether biosynthesis I
-
-
PWY-5406
divinyl ether biosynthesis II
-
-
PWY-5409
docosahexaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-7053
docosahexaenoate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7606
docosahexaenoate biosynthesis IV (4-desaturase, mammals)
-
-
PWY-7727
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichol and dolichyl phosphate biosynthesis
dolichyl-diphosphooligosaccharide biosynthesis
-
-
dopamine degradation
-
-
PWY6666-2
drosopterin and aurodrosopterin biosynthesis
-
-
PWY-7442
Drug metabolism - cytochrome P450
-
-
Drug metabolism - other enzymes
-
-
dTDP-beta-L-rhamnose biosynthesis
-
-
DTDPRHAMSYN-PWY
dTMP de novo biosynthesis (mitochondrial)
-
-
PWY66-385
dZTP biosynthesis
-
-
PWY-8289
ecdysone and 20-hydroxyecdysone biosynthesis
-
-
PWY-7300
ectoine biosynthesis
-
-
P101-PWY
elloramycin biosynthesis
-
-
enterobacterial common antigen biosynthesis
-
-
ECASYN-PWY
enterobactin biosynthesis
Entner Doudoroff pathway
-
-
Entner-Doudoroff pathway I
-
-
PWY-8004
Entner-Doudoroff pathway II (non-phosphorylative)
-
-
NPGLUCAT-PWY
Entner-Doudoroff pathway III (semi-phosphorylative)
-
-
PWY-2221
epoxypseudoisoeugenol-2-methylbutanoate biosynthesis
-
-
PWY-5882
epoxysqualene biosynthesis
-
-
PWY-5670
ergosterol biosynthesis II
-
-
PWY-7154
ergothioneine biosynthesis I (bacteria)
-
-
PWY-7255
erythritol biosynthesis I
-
-
PWY-8372
erythritol biosynthesis II
-
-
PWY-8373
erythro-tetrahydrobiopterin biosynthesis I
-
-
PWY-5663
erythromycin D biosynthesis
-
-
PWY-7106
Escherichia coli serotype O:104 O antigen biosynthesis
-
-
PWY-7530
Escherichia coli serotype O:107 O antigen biosynthesis
-
-
PWY-8219
Escherichia coli serotype O:111/Salmonella enterica serotype O:35 O antigen biosynthesis
-
-
PWY-8221
Escherichia coli serotype O:117 O antigen biosynthesis
-
-
PWY-8220
Escherichia coli serotype O:127 O antigen biosynthesis
-
-
PWY-8231
Escherichia coli serotype O:128 O antigen biosynthesis
-
-
PWY-8222
Escherichia coli serotype O:149/Shigella boydii serotype O1 O antigen biosynthesis
-
-
PWY-8253
Escherichia coli serotype O:15 O antigen biosynthesis
-
-
PWY-8209
Escherichia coli serotype O:152 O antigen biosynthesis
-
-
PWY-8226
Escherichia coli serotype O:157/Salmonella enterica serotype O:30 O antigen biosynthesis
-
-
PWY-8224
Escherichia coli serotype O:169 O antigen biosynthesis
-
-
PWY-8233
Escherichia coli serotype O:177 O antigen biosynthesis
-
-
PWY-8244
Escherichia coli serotype O:183/Shigella boydii serotype O:10 O antigen biosynthesis
-
-
PWY-8234
Escherichia coli serotype O:1B/Salmonella enterica serotype O:42 O antigen biosynthesis
-
-
PWY-8237
Escherichia coli serotype O:2 O antigen biosynthesis
-
-
PWY-8251
Escherichia coli serotype O:21/Salmonella enterica serotype O:38 O antigen biosynthesis
-
-
PWY-8235
Escherichia coli serotype O:49 O antigen biosynthesis
-
-
PWY-8272
Escherichia coli serotype O:50 O antigen biosynthesis
-
-
PWY-8252
Escherichia coli serotype O:51/Salmonella enterica serotype O:57 O antigen biosynthesis
-
-
PWY-8242
Escherichia coli serotype O:52 O antigen biosynthesis
-
-
PWY-8257
Escherichia coli serotype O:55/Salmonella enterica serotype O:50 O antigen biosynthesis
-
-
PWY-8217
Escherichia coli serotype O:56 O antigen biosynthesis
-
-
PWY-8218
Escherichia coli serotype O:7 O antigen biosynthesis
-
-
PWY-8211
Escherichia coli serotype O:71/Salmonella enterica serotype O:28ac O antigen biosynthesis
-
-
PWY-8241
Escherichia coli serotype O:77/Salmonella enterica serotype O:6,14 O antigen biosynthesis
-
-
PWY-8205
Escherichia coli serotype O:8 O antigen biosynthesis
-
-
PWY-8212
Escherichia coli serotype O:85/Salmonella enterica serotype O:17 O antigen biosynthesis
-
-
PWY-8207
Escherichia coli serotype O:86 O antigen biosynthesis
-
-
PWY-7290
Escherichia coli serotype O:9 O antigen biosynthesis
-
-
PWY-8250
Escherichia coli serotype O:9a O antigen biosynthesis
-
-
PWY-7905
estradiol biosynthesis I (via estrone)
-
-
PWY66-380
ethanol degradation I
-
-
ETOH-ACETYLCOA-ANA-PWY
ethanol degradation II
-
-
PWY66-21
ethanol degradation III
-
-
PWY66-161
ethanol degradation IV
-
-
PWY66-162
ethanolamine utilization
-
-
PWY0-1477
ethene biosynthesis I (plants)
-
-
ETHYL-PWY
ethene biosynthesis II (microbes)
-
-
PWY-6853
ethene biosynthesis III (microbes)
-
-
PWY-6854
ethene biosynthesis IV (engineered)
-
-
PWY-7126
ethene biosynthesis V (engineered)
-
-
PWY-7124
Ether lipid metabolism
-
-
Ethylbenzene degradation
-
-
ethylbenzene degradation (anaerobic)
-
-
PWY-481
ethylmalonyl-CoA pathway
-
-
PWY-5741
eugenol and isoeugenol biosynthesis
-
-
PWY-5859
eumelanin biosynthesis
-
-
PWY-6498
even iso-branched-chain fatty acid biosynthesis
-
-
PWY-8175
farnesylcysteine salvage pathway
-
-
PWY-6577
fatty acid alpha-oxidation I (plants)
-
-
PWY-2501
fatty acid beta-oxidation I (generic)
-
-
FAO-PWY
fatty acid beta-oxidation II (plant peroxisome)
-
-
PWY-5136
fatty acid beta-oxidation III (unsaturated, odd number)
-
-
PWY-5137
fatty acid beta-oxidation IV (unsaturated, even number)
-
-
PWY-5138
fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)
-
-
PWY-6837
fatty acid beta-oxidation VI (mammalian peroxisome)
-
-
PWY66-391
fatty acid beta-oxidation VII (yeast peroxisome)
-
-
PWY-7288
Fatty acid biosynthesis
-
-
fatty acid biosynthesis initiation (mitochondria)
-
-
PWY66-429
fatty acid biosynthesis initiation (plant mitochondria)
-
-
PWY-6799
fatty acid biosynthesis initiation (type I)
-
-
PWY-5966-1
fatty acid biosynthesis initiation (type II)
-
-
PWY-4381
Fatty acid degradation
-
-
Fatty acid elongation
-
-
fatty acid elongation -- saturated
-
-
FASYN-ELONG-PWY
fatty acid salvage
-
-
PWY-7094
Fe(II) oxidation
-
-
PWY-6692
felinine and 3-methyl-3-sulfanylbutan-1-ol biosynthesis
-
-
PWY-8001
FeMo cofactor biosynthesis
-
-
PWY-7710
ferrichrome A biosynthesis
-
-
PWY-7571
firefly bioluminescence
-
-
PWY-7913
flavin biosynthesis I (bacteria and plants)
-
-
RIBOSYN2-PWY
flavin biosynthesis II (archaea)
-
-
PWY-6167
flavin biosynthesis III (fungi)
-
-
PWY-6168
flavin salvage
-
-
PWY66-366
Flavone and flavonol biosynthesis
-
-
flavonoid biosynthesis
-
-
PWY1F-FLAVSYN
Flavonoid biosynthesis
-
-
flavonoid biosynthesis (in equisetum)
-
-
PWY-6787
flavonoid di-C-glucosylation
-
-
PWY-7897
flexixanthin biosynthesis
-
-
PWY-7947
fluoroacetate and fluorothreonine biosynthesis
-
-
PWY-6644
Fluorobenzoate degradation
-
-
folate transformations I
-
-
PWY-2201
folate transformations II (plants)
-
-
PWY-3841
folate transformations III (E. coli)
-
-
1CMET2-PWY
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
formaldehyde assimilation II (assimilatory RuMP Cycle)
-
-
PWY-1861
formaldehyde assimilation III (dihydroxyacetone cycle)
-
-
P185-PWY
formaldehyde oxidation
-
-
formaldehyde oxidation I
-
-
RUMP-PWY
formaldehyde oxidation II (glutathione-dependent)
-
-
PWY-1801
formaldehyde oxidation IV (thiol-independent)
-
-
FORMASS-PWY
formaldehyde oxidation VII (THF pathway)
-
-
PWY-7909
formate assimilation into 5,10-methylenetetrahydrofolate
-
-
PWY-1722
formate oxidation to CO2
-
-
PWY-1881
formate to dimethyl sulfoxide electron transfer
-
-
PWY0-1356
formate to nitrite electron transfer
-
-
PWY0-1585
formononetin conjugates interconversion
-
-
PWY-2904
fructan degradation
-
-
PWY-862
fructose 2,6-bisphosphate biosynthesis
-
-
PWY66-423
Fructose and mannose metabolism
-
-
fusicoccin A biosynthesis
-
-
PWY-6659
GABA shunt I
-
-
GLUDEG-I-PWY
GABA shunt II
-
-
PWY-8346
gala-series glycosphingolipids biosynthesis
-
-
PWY-7840
gallate degradation III (anaerobic)
-
-
P3-PWY
gamma-butyrobetaine degradation II
-
-
PWY-3621
gamma-glutamyl cycle
-
-
PWY-4041
gamma-hexachlorocyclohexane degradation
-
-
GAMMAHEXCHLORDEG-PWY
gamma-linolenate biosynthesis II (animals)
-
-
PWY-6000
ganglio-series glycosphingolipids biosynthesis
-
-
PWY-7836
GDP-6-deoxy-D-talose biosynthesis
-
-
PWY-5738
GDP-alpha-D-glucose biosynthesis
-
-
PWY-5661
GDP-D-perosamine biosynthesis
-
-
PWY-5739
GDP-D-rhamnose biosynthesis
-
-
GDPRHAMSYN-PWY
GDP-L-colitose biosynthesis
-
-
PWY-5740
GDP-L-fucose biosynthesis I (from GDP-D-mannose)
-
-
PWY-66
GDP-L-fucose biosynthesis II (from L-fucose)
-
-
PWY-6
GDP-mannose biosynthesis
-
-
PWY-5659
GDP-mycosamine biosynthesis
-
-
PWY-7573
GDP-N-acetyl-alpha-D-perosamine biosynthesis
-
-
PWY-8225
GDP-N-formyl-alpha-D-perosamine biosynthesis
-
-
PWY2B4Q-2
genistein conjugates interconversion
-
-
PWY-2345
geranyl acetate biosynthesis
-
-
PWY-5835
geranyl diphosphate biosynthesis
-
-
PWY-5122
geranylgeranyl diphosphate biosynthesis
-
-
PWY-5120
ginkgotoxin biosynthesis
-
-
PWY-8077
ginsenoside metabolism
-
-
gliotoxin biosynthesis
-
-
PWY-7533
globo-series glycosphingolipids biosynthesis
-
-
PWY-7838
glucocorticoid biosynthesis
-
-
PWY66-381
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
glucose and glucose-1-phosphate degradation
-
-
GLUCOSE1PMETAB-PWY
glucose degradation (oxidative)
-
-
DHGLUCONATE-PYR-CAT-PWY
glucosinolate activation
-
-
PWY-5267
Glucosinolate biosynthesis
-
-
glucosinolate biosynthesis from dihomomethionine
-
-
PWYQT-4471
glucosinolate biosynthesis from hexahomomethionine
-
-
PWYQT-4475
glucosinolate biosynthesis from homomethionine
-
-
PWY-1187
glucosinolate biosynthesis from pentahomomethionine
-
-
PWYQT-4474
glucosinolate biosynthesis from phenylalanine
-
-
PWY-2821
glucosinolate biosynthesis from tetrahomomethionine
-
-
PWYQT-4473
glucosinolate biosynthesis from trihomomethionine
-
-
PWYQT-4472
glucosinolate biosynthesis from tryptophan
-
-
PWY-601
glucosinolate biosynthesis from tyrosine
-
-
PWY-7901
glucosylglycerol biosynthesis
-
-
PWY-7902
glutamate and glutamine metabolism
-
-
glutamate removal from folates
-
-
PWY-2161B
glutaminyl-tRNAgln biosynthesis via transamidation
-
-
PWY-5921
glutaryl-CoA degradation
-
-
PWY-5177
glutathione biosynthesis
-
-
GLUTATHIONESYN-PWY
glutathione degradation (DUG pathway)
-
-
PWY-7559
Glutathione metabolism
-
-
glutathione metabolism
-
-
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glycerol degradation I
-
-
PWY-4261
glycerol degradation II
-
-
PWY-6131
glycerol degradation to butanol
-
-
PWY-7003
glycerol degradation V
-
-
GLYCEROLMETAB-PWY
glycerol-3-phosphate shuttle
-
-
PWY-6118
glycerol-3-phosphate to cytochrome bo oxidase electron transfer
-
-
PWY0-1561
glycerol-3-phosphate to fumarate electron transfer
-
-
PWY0-1582
glycerol-3-phosphate to hydrogen peroxide electron transport
-
-
PWY0-1591
Glycerolipid metabolism
-
-
glycerophosphodiester degradation
-
-
PWY-6952
Glycerophospholipid metabolism
-
-
glycine betaine biosynthesis
-
-
glycine betaine biosynthesis I (Gram-negative bacteria)
-
-
BETSYN-PWY
glycine betaine biosynthesis II (Gram-positive bacteria)
-
-
PWY-3722
glycine betaine biosynthesis III (plants)
-
-
PWY1F-353
glycine betaine biosynthesis IV (from glycine)
-
-
P541-PWY
glycine betaine biosynthesis V (from glycine)
-
-
PWY-6004
glycine betaine degradation I
-
-
PWY-3661
glycine betaine degradation II (mammalian)
-
-
PWY-3661-1
glycine betaine degradation III
-
-
PWY-8325
glycine biosynthesis I
-
-
GLYSYN-PWY
glycine biosynthesis II
-
-
GLYCINE-SYN2-PWY
glycine biosynthesis III
-
-
GLYSYN-ALA-PWY
glycine cleavage
-
-
GLYCLEAV-PWY
glycine degradation (reductive Stickland reaction)
-
-
PWY-8015
Glycine, serine and threonine metabolism
-
-
glycogen biosynthesis
-
-
glycogen biosynthesis I (from ADP-D-Glucose)
-
-
GLYCOGENSYNTH-PWY
glycogen biosynthesis II (from UDP-D-Glucose)
-
-
PWY-5067
glycogen biosynthesis III (from alpha-maltose 1-phosphate)
-
-
PWY-7900
glycogen degradation I
-
-
GLYCOCAT-PWY
glycogen degradation II
-
-
PWY-5941
glycogen degradation III (via anhydrofructose)
-
-
PWY-7662
glycolate and glyoxylate degradation
-
-
glycolate and glyoxylate degradation III
-
-
PWY-6649
Glycolysis / Gluconeogenesis
-
-
glycolysis I (from glucose 6-phosphate)
-
-
GLYCOLYSIS
glycolysis II (from fructose 6-phosphate)
-
-
PWY-5484
glycolysis III (from glucose)
-
-
ANAGLYCOLYSIS-PWY
glycolysis IV
-
-
PWY-1042
glycolysis V (Pyrococcus)
-
-
P341-PWY
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
-
-
Glycosaminoglycan biosynthesis - heparan sulfate / heparin
-
-
Glycosaminoglycan biosynthesis - keratan sulfate
-
-
Glycosaminoglycan degradation
-
-
Glycosphingolipid biosynthesis - ganglio series
-
-
Glycosphingolipid biosynthesis - globo and isoglobo series
-
-
Glycosphingolipid biosynthesis - lacto and neolacto series
-
-
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate assimilation
-
-
PWY-5744
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
glyphosate degradation II
-
-
PWY-7806
glyphosate degradation III
-
-
PWY-7807
gondoate biosynthesis (anaerobic)
-
-
PWY-7663
gossypol biosynthesis
-
-
PWY-5773
grixazone biosynthesis
-
-
PWY-7153
guadinomine B biosynthesis
-
-
PWY-7693
guaiacol biosynthesis
-
-
PWY18C3-23
guanine and guanosine salvage I
-
-
PWY-6620
guanine and guanosine salvage II
-
-
PWY-6599
guanosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7226
guanosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7222
guanosine nucleotides degradation I
-
-
PWY-6607
guanosine nucleotides degradation II
-
-
PWY-6606
guanosine nucleotides degradation III
-
-
PWY-6608
guanosine ribonucleotides de novo biosynthesis
-
-
PWY-7221
H. pylori 26695 O-antigen biosynthesis
-
-
PWY2DNV-5
heme a biosynthesis
-
-
PWY-7856
heme b biosynthesis I (aerobic)
-
-
HEME-BIOSYNTHESIS-II
heme b biosynthesis II (oxygen-independent)
-
-
HEMESYN2-PWY
heme b biosynthesis IV (Gram-positive bacteria)
-
-
PWY-7766
heme b biosynthesis V (aerobic)
-
-
HEME-BIOSYNTHESIS-II-1
heme degradation I
-
-
PWY-5874
hemoglobin degradation
-
-
PWY-6423
heparan sulfate biosynthesis
-
-
PWY-6558
heparan sulfate degradation
-
-
PWY-7651
heparin degradation
-
-
PWY-7644
heterolactic fermentation
-
-
P122-PWY
histamine biosynthesis
-
-
PWY-6173
histamine degradation
-
-
PWY-6181
homocarnosine biosynthesis
-
-
PWY66-421
homocysteine and cysteine interconversion
-
-
PWY-801
homoglutathione biosynthesis
-
-
PWY-6840
homospermidine biosynthesis I
-
-
PWY-5907
homospermidine biosynthesis II
-
-
PWY-8149
hopanoid biosynthesis (bacteria)
-
-
PWY-7072
hyaluronan degradation
-
-
PWY-7645
hydrogen oxidation I (aerobic)
-
-
P283-PWY
hydrogen oxidation II (aerobic, NAD)
-
-
PWY-5382
hydrogen production II
-
-
PWY-6758
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
hydrogen to dimethyl sulfoxide electron transfer
-
-
PWY0-1577
hydrogen to fumarate electron transfer
-
-
PWY0-1576
hydroxycinnamic acid serotonin amides biosynthesis
-
-
PWY-5473
hydroxycinnamic acid tyramine amides biosynthesis
-
-
PWY-5474
hydroxylated fatty acid biosynthesis (plants)
-
-
PWY-6433
hyperxanthone E biosynthesis
-
-
PWY-7169
hypoglycin biosynthesis
-
-
PWY-5826
hypotaurine degradation
-
-
PWY-7387
hypusine biosynthesis
-
-
PWY-5905
i antigen and I antigen biosynthesis
-
-
PWY-7837
icosapentaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-6958
icosapentaenoate biosynthesis II (6-desaturase, mammals)
-
-
PWY-7049
icosapentaenoate biosynthesis III (8-desaturase, mammals)
-
-
PWY-7724
icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)
-
-
PWY-7602
icosapentaenoate biosynthesis VI (fungi)
-
-
PWY-6940
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
indole glucosinolate activation (herbivore attack)
-
-
PWYQT-4476
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
indole-3-acetate biosynthesis II
-
-
PWY-581
indole-3-acetate biosynthesis III (bacteria)
-
-
PWY-3161
indole-3-acetate biosynthesis IV (bacteria)
-
-
PWY-5025
indole-3-acetate biosynthesis V (bacteria and fungi)
-
-
PWY-5026
indole-3-acetate biosynthesis VI (bacteria)
-
-
TRPIAACAT-PWY
indole-3-acetate degradation II
-
-
PWY-8087
inosine 5'-phosphate degradation
-
-
PWY-5695
inosine-5'-phosphate biosynthesis I
-
-
PWY-6123
inosine-5'-phosphate biosynthesis II
-
-
PWY-6124
inosine-5'-phosphate biosynthesis III
-
-
PWY-7234
inositol diphosphates biosynthesis
-
-
PWY-6369
Inositol phosphate metabolism
-
-
Insect hormone biosynthesis
-
-
inulin degradation
-
-
PWY-8314
ipsdienol biosynthesis
-
-
PWY-7410
isoleucine metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
isoprenoid biosynthesis
-
-
isopropanol biosynthesis (engineered)
-
-
PWY-6876
Isoquinoline alkaloid biosynthesis
-
-
itaconate degradation
-
-
PWY-5749
jadomycin biosynthesis
-
-
PWY-6679
jasmonic acid biosynthesis
-
-
PWY-735
juniperonate biosynthesis
-
-
PWY-7619
justicidin B biosynthesis
-
-
PWY-6824
Kdo-lipid A biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY-8378
ketogenesis
-
-
PWY66-367
ketogluconate metabolism
-
-
L-alanine biosynthesis I
-
-
ALANINE-VALINESYN-PWY
L-alanine biosynthesis II
-
-
ALANINE-SYN2-PWY
L-alanine biosynthesis III
-
-
PWY0-1021
L-alanine degradation II (to D-lactate)
-
-
ALACAT2-PWY
L-alanine degradation III
-
-
ALANINE-DEG3-PWY
L-alanine degradation IV
-
-
PWY1-2
L-alanine degradation V (oxidative Stickland reaction)
-
-
PWY-8189
L-alanine degradation VI (reductive Stickland reaction)
-
-
PWY-8188
L-arabinose degradation II
-
-
PWY-5515
L-arginine biosynthesis I (via L-ornithine)
-
-
ARGSYN-PWY
L-arginine biosynthesis II (acetyl cycle)
-
-
ARGSYNBSUB-PWY
L-arginine biosynthesis III (via N-acetyl-L-citrulline)
-
-
PWY-5154
L-arginine biosynthesis IV (archaea)
-
-
PWY-7400
L-arginine degradation I (arginase pathway)
-
-
ARGASEDEG-PWY
L-arginine degradation II (AST pathway)
-
-
AST-PWY
L-arginine degradation V (arginine deiminase pathway)
-
-
ARGDEGRAD-PWY
L-arginine degradation VI (arginase 2 pathway)
-
-
ARG-PRO-PWY
L-arginine degradation VII (arginase 3 pathway)
-
-
ARG-GLU-PWY
L-arginine degradation X (arginine monooxygenase pathway)
-
-
ARGDEG-V-PWY
L-arginine degradation XIII (reductive Stickland reaction)
-
-
PWY-8187
L-arginine degradation XIV (oxidative Stickland reaction)
-
-
PWY-6344
L-ascorbate biosynthesis IV (animals, D-glucuronate pathway)
-
-
PWY3DJ-35471
L-ascorbate biosynthesis VI (plants, myo-inositol pathway)
-
-
PWY-8142
L-ascorbate biosynthesis VIII (engineered pathway)
-
-
PWY-7165
L-ascorbate degradation II (bacterial, aerobic)
-
-
PWY-6961
L-ascorbate degradation III
-
-
PWY-6960
L-asparagine biosynthesis I
-
-
ASPARAGINE-BIOSYNTHESIS
L-asparagine biosynthesis II
-
-
ASPARAGINESYN-PWY
L-asparagine biosynthesis III (tRNA-dependent)
-
-
PWY490-4
L-asparagine degradation I
-
-
ASPARAGINE-DEG1-PWY
L-asparagine degradation III (mammalian)
-
-
ASPARAGINE-DEG1-PWY-1
L-aspartate biosynthesis
-
-
ASPARTATESYN-PWY
L-aspartate degradation I
-
-
ASPARTATE-DEG1-PWY
L-aspartate degradation II (aerobic)
-
-
PWY-8291
L-aspartate degradation III (anaerobic)
-
-
PWY-8294
L-carnitine biosynthesis
-
-
PWY-6100
L-carnitine degradation II
-
-
PWY-3641
L-citrulline biosynthesis
-
-
CITRULBIO-PWY
L-citrulline degradation
-
-
CITRULLINE-DEG-PWY
L-cysteine biosynthesis I
-
-
CYSTSYN-PWY
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-cysteine biosynthesis IX (Trichomonas vaginalis)
-
-
PWY-8010
L-cysteine biosynthesis VI (reverse transsulfuration)
-
-
PWY-I9
L-cysteine biosynthesis VII (from S-sulfo-L-cysteine)
-
-
PWY-7870
L-cysteine degradation III
-
-
PWY-5329
L-dopa and L-dopachrome biosynthesis
-
-
PWY-6481
L-dopa degradation I (mammalian)
-
-
PWY-6334
L-dopa degradation II (bacterial)
-
-
PWY-8110
L-fucose degradation I
-
-
FUCCAT-PWY
L-fucose degradation II
-
-
PWY-8318
L-glutamate biosynthesis I
-
-
GLUTSYN-PWY
L-glutamate biosynthesis II
-
-
GLUTAMATE-SYN2-PWY
L-glutamate degradation I
-
-
GLUTAMATE-DEG1-PWY
L-glutamate degradation II
-
-
GLUTDEG-PWY
L-glutamate degradation IX (via 4-aminobutanoate)
-
-
PWY0-1305
L-glutamate degradation V (via hydroxyglutarate)
-
-
P162-PWY
L-glutamate degradation VI (to pyruvate)
-
-
PWY-5087
L-glutamate degradation VII (to butanoate)
-
-
GLUDEG-II-PWY
L-glutamate degradation X
-
-
PWY-5766
L-glutamate degradation XI (reductive Stickland reaction)
-
-
PWY-8190
L-glutamine biosynthesis I
-
-
GLNSYN-PWY
L-glutamine degradation I
-
-
GLUTAMINDEG-PWY
L-glutamine degradation II
-
-
GLUTAMINEFUM-PWY
L-histidine degradation I
-
-
HISDEG-PWY
L-histidine degradation II
-
-
PWY-5028
L-histidine degradation III
-
-
PWY-5030
L-histidine degradation V
-
-
PWY-5031
L-histidine degradation VI
-
-
HISHP-PWY
L-homophenylalanine biosynthesis
-
-
PWY-7275
L-homoserine biosynthesis
-
-
HOMOSERSYN-PWY
L-idonate degradation
-
-
IDNCAT-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine biosynthesis V
-
-
PWY-5108
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-isoleucine degradation III (oxidative Stickland reaction)
-
-
PWY-8184
L-lactaldehyde degradation
-
-
L-leucine biosynthesis
-
-
LEUSYN-PWY
L-leucine degradation I
-
-
LEU-DEG2-PWY
L-leucine degradation III
-
-
PWY-5076
L-leucine degradation IV (reductive Stickland reaction)
-
-
PWY-7767
L-leucine degradation V (oxidative Stickland reaction)
-
-
PWY-8185
L-lysine biosynthesis I
-
-
DAPLYSINESYN-PWY
L-lysine biosynthesis II
-
-
PWY-2941
L-lysine biosynthesis III
-
-
PWY-2942
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-lysine biosynthesis VI
-
-
PWY-5097
L-lysine degradation I
-
-
PWY0-461
L-lysine degradation II (L-pipecolate pathway)
-
-
PWY66-425
L-lysine degradation V
-
-
PWY-5283
L-lysine degradation X
-
-
PWY-6328
L-lysine degradation XI
-
-
LYSINE-DEG1-PWY
L-lysine fermentation to acetate and butanoate
-
-
P163-PWY
L-malate degradation II
-
-
PWY-7686
L-methionine biosynthesis I
-
-
HOMOSER-METSYN-PWY
L-methionine biosynthesis II
-
-
PWY-702
L-methionine biosynthesis III
-
-
HSERMETANA-PWY
L-methionine biosynthesis IV
-
-
PWY-7977
L-methionine degradation I (to L-homocysteine)
-
-
METHIONINE-DEG1-PWY
L-methionine degradation III
-
-
PWY-5082
L-methionine salvage from L-homocysteine
-
-
ADENOSYLHOMOCYSCAT-PWY
L-Ndelta-acetylornithine biosynthesis
-
-
PWY-6922
L-nicotianamine biosynthesis
-
-
PWY-5957
L-ornithine biosynthesis I
-
-
GLUTORN-PWY
L-ornithine biosynthesis II
-
-
ARGININE-SYN4-PWY
L-ornithine degradation I (L-proline biosynthesis)
-
-
ORN-AMINOPENTANOATE-CAT-PWY
L-phenylalanine biosynthesis I
-
-
PHESYN
L-phenylalanine biosynthesis III (cytosolic, plants)
-
-
PWY-7432
L-phenylalanine degradation I (aerobic)
-
-
PHENYLALANINE-DEG1-PWY
L-phenylalanine degradation II (anaerobic)
-
-
ANAPHENOXI-PWY
L-phenylalanine degradation III
-
-
PWY-5079
L-phenylalanine degradation IV (mammalian, via side chain)
-
-
PWY-6318
L-phenylalanine degradation V
-
-
PWY-7158
L-phenylalanine degradation VI (reductive Stickland reaction)
-
-
PWY-8014
L-proline biosynthesis I (from L-glutamate)
-
-
PROSYN-PWY
L-proline biosynthesis II (from arginine)
-
-
PWY-4981
L-proline biosynthesis III (from L-ornithine)
-
-
PWY-3341
L-proline biosynthesis IV
-
-
PWY-4281
L-proline degradation I
-
-
PROUT-PWY
L-selenocysteine biosynthesis I (bacteria)
-
-
PWY0-901
L-selenocysteine biosynthesis II (archaea and eukaryotes)
-
-
PWY-6281
L-serine biosynthesis I
-
-
SERSYN-PWY
L-serine biosynthesis II
-
-
PWY-8011
L-threonine biosynthesis
-
-
HOMOSER-THRESYN-PWY
L-threonine degradation I
-
-
PWY-5437
L-threonine degradation II
-
-
THREONINE-DEG2-PWY
L-threonine degradation III (to methylglyoxal)
-
-
THRDLCTCAT-PWY
L-tryptophan degradation I (via anthranilate)
-
-
TRPCAT-PWY
L-tryptophan degradation IV (via indole-3-lactate)
-
-
TRPKYNCAT-PWY
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5651
L-tryptophan degradation V (side chain pathway)
-
-
PWY-3162
L-tryptophan degradation VI (via tryptamine)
-
-
PWY-3181
L-tryptophan degradation VIII (to tryptophol)
-
-
PWY-5081
L-tryptophan degradation X (mammalian, via tryptamine)
-
-
PWY-6307
L-tryptophan degradation XI (mammalian, via kynurenine)
-
-
PWY-6309
L-tryptophan degradation XIII (reductive Stickland reaction)
-
-
PWY-8017
L-tyrosine biosynthesis I
-
-
TYRSYN
L-tyrosine biosynthesis IV
-
-
PWY-6134
L-tyrosine degradation I
-
-
TYRFUMCAT-PWY
L-tyrosine degradation II
-
-
PWY-5151
L-tyrosine degradation III
-
-
PWY3O-4108
L-tyrosine degradation IV (to 4-methylphenol)
-
-
PWY-7514
L-tyrosine degradation V (reductive Stickland reaction)
-
-
PWY-8016
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation I
-
-
VALDEG-PWY
L-valine degradation II
-
-
PWY-5057
L-valine degradation III (oxidative Stickland reaction)
-
-
PWY-8183
lacinilene C biosynthesis
-
-
PWY-5828
lactate fermentation to acetate, CO2 and hydrogen (Desulfovibrionales)
-
-
PWY-8377
lacto-series glycosphingolipids biosynthesis
-
-
PWY-7839
lactose degradation III
-
-
BGALACT-PWY
lanosterol biosynthesis
-
-
PWY-6132
leukotriene biosynthesis
-
-
PWY66-375
Limonene and pinene degradation
-
-
limonene degradation IV (anaerobic)
-
-
PWY-8029
linalool biosynthesis I
-
-
PWY-7182
linamarin degradation
-
-
PWY-3121
linezolid resistance
-
-
PWY-6828
linoleate biosynthesis I (plants)
-
-
PWY-5995
linoleate biosynthesis II (animals)
-
-
PWY-6001
linoleate metabolites biosynthesis
-
-
PWY-8395
Linoleic acid metabolism
-
-
linustatin bioactivation
-
-
PWY-7091
lipid A-core biosynthesis (E. coli K-12)
-
-
LIPA-CORESYN-PWY
lipid IVA biosynthesis (2,3-diamino-2,3-dideoxy-D-glucopyranose-containing)
-
-
PWY2B4Q-4
lipid IVA biosynthesis (E. coli)
-
-
NAGLIPASYN-PWY
lipid IVA biosynthesis (generic)
-
-
PWY-8283
lipid IVA biosynthesis (H. pylori)
-
-
PWYI-14
lipid IVA biosynthesis (P. gingivalis)
-
-
PWY-8245
lipid IVA biosynthesis (P. putida)
-
-
PWY-8073
lipid IVA biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY2G6Z-2
lipoate biosynthesis and incorporation II
-
-
PWY0-1275
Lipoic acid metabolism
-
-
Lipopolysaccharide biosynthesis
-
-
lipoprotein posttranslational modification
-
-
PWY-7884
lipoxin biosynthesis
-
-
PWY66-392
long chain fatty acid ester synthesis (engineered)
-
-
PWY-6873
long-chain fatty acid activation
-
-
PWY-5143
lotaustralin degradation
-
-
PWY-6002
lupulone and humulone biosynthesis
-
-
PWY-5132
luteolin triglucuronide degradation
-
-
PWY-7445
lychnose and isolychnose biosynthesis
-
-
PWY-6524
macrolide antibiotic biosynthesis
-
-
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
mandelate degradation I
-
-
PWY-1501
manganese oxidation I
-
-
PWY-6591
mangrove triterpenoid biosynthesis
-
-
PWY-6109
mannitol biosynthesis
-
-
PWY-3881
mannitol cycle
-
-
PWY-6531
mannitol degradation I
-
-
MANNIDEG-PWY
mannitol degradation II
-
-
PWY-3861
Mannose type O-glycan biosynthesis
-
-
mannosylglycerate biosynthesis
-
-
mannosylglycerate biosynthesis I
-
-
PWY-5656
maresin biosynthesis
-
-
PWY-8356
matairesinol biosynthesis
-
-
PWY-5466
melatonin degradation I
-
-
PWY-6398
melatonin degradation II
-
-
PWY-6399
melibiose degradation
-
-
PWY0-1301
metabolism of amino sugars and derivatives
-
-
metabolism of disaccharids
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
Methanobacterium thermoautotrophicum biosynthetic metabolism
-
-
PWY-6146
methanofuran biosynthesis
-
-
PWY-5254
methanogenesis from acetate
-
-
METH-ACETATE-PWY
methanogenesis from CO2
-
-
methanogenesis from H2 and CO2
-
-
METHANOGENESIS-PWY
methanol oxidation to carbon dioxide
-
-
PWY-7616
methanol oxidation to formaldehyde IV
-
-
PWY-5506
methiin metabolism
-
-
PWY-7614
methionine metabolism
-
-
methoxylated aromatic compound degradation II
-
-
PWY-8305
methyl indole-3-acetate interconversion
-
-
PWY-6303
methyl ketone biosynthesis (engineered)
-
-
PWY-7007
methyl parathion degradation
-
-
PWY-5489
methyl phomopsenoate biosynthesis
-
-
PWY-7721
methyl tert-butyl ether degradation
-
-
PWY-7779
methyl-coenzyme M oxidation to CO2
-
-
PWY-5209
methyl-coenzyme M reduction to methane
-
-
METHFORM-PWY
methylamine degradation I
-
-
PWY-6967
methylerythritol phosphate pathway I
-
-
NONMEVIPP-PWY
methylerythritol phosphate pathway II
-
-
PWY-7560
methylgallate degradation
-
-
METHYLGALLATE-DEGRADATION-PWY
methylglyoxal degradation
-
-
methylglyoxal degradation I
-
-
PWY-5386
methylglyoxal degradation III
-
-
PWY-5453
methylglyoxal degradation V
-
-
PWY-5458
methylglyoxal degradation VI
-
-
MGLDLCTANA-PWY
methylglyoxal degradation VIII
-
-
PWY-5386-1
methylsalicylate degradation
-
-
PWY18C3-24
mevalonate degradation
-
-
PWY-5074
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
Microbial metabolism in diverse environments
-
-
mineralocorticoid biosynthesis
-
-
PWY66-382
mitochondrial L-carnitine shuttle
-
-
PWY-6111
mitochondrial NADPH production (yeast)
-
-
PWY-7269
mixed acid fermentation
-
-
FERMENTATION-PWY
molybdenum cofactor biosynthesis
-
-
molybdenum cofactor sulfulylation (eukaryotes)
-
-
PWY-5963
molybdopterin biosynthesis
-
-
PWY-6823
momilactone A biosynthesis
-
-
PWY-7477
mono-trans, poly-cis decaprenyl phosphate biosynthesis
-
-
PWY-6383
monoacylglycerol metabolism (yeast)
-
-
PWY-7420
Monobactam biosynthesis
-
-
mRNA capping I
-
-
PWY-7375
mRNA capping II
-
-
PWY-7379
mucin core 1 and core 2 O-glycosylation
-
-
PWY-7433
mucin core 3 and core 4 O-glycosylation
-
-
PWY-7435
Mucin type O-glycan biosynthesis
-
-
mupirocin biosynthesis
-
-
PWY-8012
muropeptide degradation
-
-
PWY0-1546
mycobactin biosynthesis
-
-
PWY185E-1
mycolate biosynthesis
-
-
PWYG-321
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis
-
-
PWY-6397
mycothiol biosynthesis
-
-
PWY1G-0
myo-, chiro- and scyllo-inositol degradation
-
-
PWY-7237
myo-inositol biosynthesis
myo-inositol degradation I
-
-
P562-PWY
myo-inositol degradation II
-
-
PWY-7241
N-3-oxalyl-L-2,3-diaminopropanoate biosynthesis
-
-
PWY-8071
N-acetylglucosamine degradation I
-
-
GLUAMCAT-PWY
N-acetylglucosamine degradation II
-
-
PWY-6517
N-acetylneuraminate and N-acetylmannosamine degradation I
-
-
PWY0-1324
N-acetylneuraminate and N-acetylmannosamine degradation II
-
-
PWY-7581
N-Glycan biosynthesis
-
-
N-hydroxy-L-pipecolate biosynthesis
-
-
PWY-7861
N-methylpyrrolidone degradation
-
-
PWY-7978
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5653
NAD biosynthesis from nicotinamide
-
-
NAD-BIOSYNTHESIS-III
NAD de novo biosynthesis I
-
-
PYRIDNUCSYN-PWY
NAD de novo biosynthesis III
-
-
PWY-8352
NAD de novo biosynthesis IV (anaerobic)
-
-
PWY-8277
NAD phosphorylation and dephosphorylation
-
-
NADPHOS-DEPHOS-PWY
NAD phosphorylation and transhydrogenation
-
-
NADPHOS-DEPHOS-PWY-1
NAD salvage (plants)
-
-
PWY-5381
NAD salvage pathway I (PNC VI cycle)
-
-
PYRIDNUCSAL-PWY
NAD salvage pathway II (PNC IV cycle)
-
-
PWY-7761
NAD salvage pathway III (to nicotinamide riboside)
-
-
NAD-BIOSYNTHESIS-II
NAD salvage pathway IV (from nicotinamide riboside)
-
-
PWY3O-4106
NAD salvage pathway V (PNC V cycle)
-
-
PWY3O-4107
NAD(P)/NADPH interconversion
-
-
PWY-5083
NADH to cytochrome bd oxidase electron transfer I
-
-
PWY0-1334
NADH to cytochrome bo oxidase electron transfer I
-
-
PWY0-1335
NADH to dimethyl sulfoxide electron transfer
-
-
PWY0-1348
NADH to fumarate electron transfer
-
-
PWY0-1336
NADP biosynthesis
-
-
PWY-8148
NADPH to cytochrome c oxidase via plastocyanin
-
-
PWY-8271
Naphthalene degradation
-
-
naringenin biosynthesis (engineered)
-
-
PWY-7397
neolacto-series glycosphingolipids biosynthesis
-
-
PWY-7841
neolinustatin bioactivation
-
-
PWY-7092
Neomycin, kanamycin and gentamicin biosynthesis
-
-
Nicotinate and nicotinamide metabolism
-
-
nicotine biosynthesis
-
-
PWY-5316
nicotine degradation I (pyridine pathway)
-
-
P181-PWY
nicotine degradation IV
-
-
PWY66-201
nicotine degradation V
-
-
PWY66-221
nitrate reduction I (denitrification)
-
-
DENITRIFICATION-PWY
nitrate reduction II (assimilatory)
-
-
PWY-381
nitrate reduction IX (dissimilatory)
-
-
PWY0-1581
nitrate reduction VII (denitrification)
-
-
PWY-6748
nitrate reduction X (dissimilatory, periplasmic)
-
-
PWY0-1584
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
nitrifier denitrification
-
-
PWY-7084
nitrite-dependent anaerobic methane oxidation
-
-
PWY-6523
nitroethane degradation
-
-
PWY-5355
nitrogen fixation I (ferredoxin)
-
-
N2FIX-PWY
nitrogen remobilization from senescing leaves
-
-
PWY-6549
Nitrotoluene degradation
-
-
nocardicin A biosynthesis
-
-
PWY-7797
noradrenaline and adrenaline degradation
-
-
PWY-6342
norspermidine biosynthesis
-
-
PWY-6562
Novobiocin biosynthesis
-
-
nucleoside and nucleotide degradation (archaea)
-
-
PWY-5532
O-antigen biosynthesis
-
-
O-antigen building blocks biosynthesis (E. coli)
-
-
OANTIGEN-PWY
O-Antigen nucleotide sugar biosynthesis
-
-
o-diquinones biosynthesis
-
-
PWY-6752
octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)
-
-
PWY-7388
octopamine biosynthesis
-
-
PWY-7297
odd iso-branched-chain fatty acid biosynthesis
-
-
PWY-8174
oleandomycin activation/inactivation
-
-
PWY-6972
oleate beta-oxidation
-
-
PWY0-1337
oleate beta-oxidation (isomerase-dependent, yeast)
-
-
PWY-7291
oleate beta-oxidation (reductase-dependent, yeast)
-
-
PWY-7307
oleate beta-oxidation (thioesterase-dependent, yeast)
-
-
PWY-7292
oleate biosynthesis I (plants)
-
-
PWY-5147
oleate biosynthesis II (animals and fungi)
-
-
PWY-5996
oleate biosynthesis III (cyanobacteria)
-
-
PWY-7587
oleate biosynthesis IV (anaerobic)
-
-
PWY-7664
One carbon pool by folate
-
-
ophiobolin F biosynthesis
-
-
PWY-7720
ophthalmate biosynthesis
-
-
PWY-8043
Other glycan degradation
-
-
Other types of O-glycan biosynthesis
-
-
oxalate degradation II
-
-
PWY-6695
oxalate degradation III
-
-
PWY-6696
oxalate degradation VI
-
-
PWY-7985
oxidative decarboxylation of pyruvate
-
-
Oxidative phosphorylation
-
-
oxidative phosphorylation
-
-
palmitate biosynthesis
-
-
palmitate biosynthesis I (type I fatty acid synthase)
-
-
PWY-5994
palmitate biosynthesis II (type II fatty acid synthase)
-
-
PWY-5971
palmitate biosynthesis III
-
-
PWY-8279
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate)
-
-
PWY-6282
palmitoleate biosynthesis III (cyanobacteria)
-
-
PWY-7589
palmitoleate biosynthesis IV (fungi and animals)
-
-
PWY3O-1801
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
Pantothenate and CoA biosynthesis
-
-
pantothenate biosynthesis
-
-
paraoxon degradation
-
-
PWY-5490
parathion degradation
-
-
PARATHION-DEGRADATION-PWY
partial TCA cycle (obligate autotrophs)
-
-
PWY-5913
paspaline biosynthesis
-
-
PWY-7492
pectin degradation I
-
-
PWY-7246
pectin degradation II
-
-
PWY-7248
pederin biosynthesis
-
-
PWY-8049
Penicillin and cephalosporin biosynthesis
-
-
pentachlorophenol degradation
-
-
PCPDEG-PWY
pentacyclic triterpene biosynthesis
-
-
PWY-7251
Pentose and glucuronate interconversions
-
-
Pentose phosphate pathway
-
-
pentose phosphate pathway
-
-
pentose phosphate pathway (non-oxidative branch) I
-
-
NONOXIPENT-PWY
pentose phosphate pathway (non-oxidative branch) II
-
-
PWY-8178
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
pentose phosphate pathway (partial)
-
-
P21-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
Peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis I (meso-diaminopimelate containing)
-
-
PEPTIDOGLYCANSYN-PWY
peptidoglycan biosynthesis II (staphylococci)
-
-
PWY-5265
peptidoglycan biosynthesis III (mycobacteria)
-
-
PWY-6385
peptidoglycan biosynthesis IV (Enterococcus faecium)
-
-
PWY-6471
peptidoglycan biosynthesis V (beta-lactam resistance)
-
-
PWY-6470
peptidoglycan maturation (meso-diaminopimelate containing)
-
-
PWY0-1586
peptidoglycan recycling I
-
-
PWY0-1261
peptidoglycan recycling II
-
-
PWY-7883
petrobactin biosynthesis
-
-
PWY-6289
petroselinate biosynthesis
-
-
PWY-5367
phenylacetate degradation (aerobic)
-
-
phenylacetate degradation I (aerobic)
-
-
PWY0-321
Phenylalanine metabolism
-
-
phenylalanine metabolism
-
-
Phenylalanine, tyrosine and tryptophan biosynthesis
-
-
phenylethanol biosynthesis
-
-
PWY-5751
phenylethyl acetate biosynthesis
-
-
PWY-7075
phenylethylamine degradation I
-
-
2PHENDEG-PWY
phenylmercury acetate degradation
phenylpropanoid biosynthesis
-
-
PWY-361
Phenylpropanoid biosynthesis
-
-
phenylpropanoid biosynthesis
-
-
phenylpropanoids methylation (ice plant)
-
-
PWY-7498
pheomelanin biosynthesis
-
-
PWY-7917
phloridzin biosynthesis
-
-
PWY-6515
phosphate acquisition
-
-
PWY-6348
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phosphatidylcholine acyl editing
-
-
PWY-6803
phosphatidylcholine biosynthesis I
-
-
PWY3O-450
phosphatidylcholine biosynthesis II
-
-
PWY4FS-2
phosphatidylcholine biosynthesis III
-
-
PWY4FS-3
phosphatidylcholine biosynthesis IV
-
-
PWY4FS-4
phosphatidylcholine biosynthesis V
-
-
PWY-6825
phosphatidylcholine biosynthesis VII
-
-
PWY-7470
phosphatidylcholine resynthesis via glycerophosphocholine
-
-
PWY-7367
phosphatidylethanolamine biosynthesis II
-
-
PWY4FS-6
phosphatidylethanolamine biosynthesis III
-
-
PWY-6273
phosphatidylethanolamine bioynthesis
-
-
phosphatidylglycerol biosynthesis I
-
-
PWY4FS-7
phosphatidylglycerol biosynthesis II
-
-
PWY4FS-8
phosphatidylinositol biosynthesis I (bacteria)
-
-
PWY-6580
phosphatidylinositol biosynthesis II (eukaryotes)
-
-
PWY-7625
phosphatidylserine and phosphatidylethanolamine biosynthesis I
-
-
PWY-5669
phosphatidylserine biosynthesis I
-
-
PWY-7501
phosphatidylserine biosynthesis II
-
-
PWY-7506
phospholipases
-
-
LIPASYN-PWY
phospholipid desaturation
-
-
PWY-762
phospholipid remodeling (phosphatidate, yeast)
-
-
PWY-7417
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phospholipid remodeling (phosphatidylethanolamine, yeast)
-
-
PWY-7409
Phosphonate and phosphinate metabolism
-
-
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
phosphopantothenate biosynthesis II
-
-
PWY-3961
photorespiration I
-
-
PWY-181
photorespiration II
-
-
PWY-8362
photorespiration III
-
-
PWY-8363
photosynthesis light reactions
-
-
PWY-101
photosynthetic 3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7218
phytate degradation I
-
-
PWY-4702
phytate degradation II
-
-
PWY-4781
phytochelatins biosynthesis
-
-
PWY-6745
phytochromobilin biosynthesis
-
-
PWY-7170
phytol degradation
-
-
PWY66-389
phytosterol biosynthesis (plants)
-
-
PWY-2541
pinitol biosynthesis I
-
-
PWY-6738
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
plasmalogen degradation
-
-
PWY-7783
plastoquinol-9 biosynthesis I
-
-
PWY-1581
platensimycin biosynthesis
-
-
PWY-8179
plaunotol biosynthesis
-
-
PWY-6691
poly(3-O-beta-D-glucopyranosyl-N-acetylgalactosamine 1-phosphate) wall teichoic acid biosynthesis
-
-
PWY-7819
poly(glycerol phosphate) wall teichoic acid biosynthesis
-
-
TEICHOICACID-PWY
poly(ribitol phosphate) wall teichoic acid biosynthesis I (B. subtilis)
-
-
PWY-7815
poly(ribitol phosphate) wall teichoic acid biosynthesis II (S. aureus)
-
-
PWY-7816
poly-hydroxy fatty acids biosynthesis
-
-
PWY-6710
polybrominated dihydroxylated diphenyl ethers biosynthesis
-
-
PWY-7934
Polycyclic aromatic hydrocarbon degradation
-
-
polyethylene terephthalate degradation
-
-
PWY-7794
polyhydroxybutanoate biosynthesis
-
-
PWY1-3
polyhydroxydecanoate biosynthesis
-
-
PWY-6657
polyphosphate metabolism
-
-
PWY-8138
Porphyrin and chlorophyll metabolism
-
-
ppGpp metabolism
-
-
PPGPPMET-PWY
preQ0 biosynthesis
-
-
PWY-6703
Primary bile acid biosynthesis
-
-
procollagen hydroxylation and glycosylation
-
-
PWY-7894
progesterone biosynthesis
-
-
PWY-7299
proline to cytochrome bo oxidase electron transfer
-
-
PWY0-1544
propanethial S-oxide biosynthesis
-
-
PWY-5707
propanoate fermentation to 2-methylbutanoate
-
-
PWY-5109
Propanoate metabolism
-
-
propanoyl CoA degradation I
-
-
PROPIONMET-PWY
propanoyl-CoA degradation II
-
-
PWY-7574
propionate fermentation
-
-
protectin biosynthesis
-
-
PWY-8357
protective electron sinks in the thylakoid membrane (PSII to PTOX)
-
-
PWY1YI0-7
protein citrullination
-
-
PWY-4921
protein N-glycosylation (Haloferax volcanii)
-
-
PWY-7661
protein N-glycosylation initial phase (eukaryotic)
-
-
MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS
protein N-glycosylation processing of mannoproteins (cis-Golgi, yeast)
-
-
PWY-8323
protein N-glycosylation processing of proteins targeted for retention in cellular organelles (cis-Golgi, yeast)
-
-
PWY-8322
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein O-mannosylation I (yeast)
-
-
PWY-7921
protein O-mannosylation II (mammals, core M1 and core M2)
-
-
PWY-7922
protein O-mannosylation III (mammals, core M3)
-
-
PWY-7979
protein O-[N-acetyl]-glucosylation
-
-
PWY-7437
protein S-nitrosylation and denitrosylation
-
-
PWY-7798
protein ubiquitination
-
-
PWY-7511
protocatechuate degradation I (meta-cleavage pathway)
-
-
P184-PWY
PRPP biosynthesis
-
-
PWY0-662
pseudouridine degradation
-
-
PWY-6019
psilocybin biosynthesis
-
-
PWY-7936
purine deoxyribonucleosides degradation I
-
-
PWY-7179
purine deoxyribonucleosides degradation II
-
-
PWY-7179-1
purine deoxyribonucleosides salvage
-
-
PWY-7224
purine nucleobases degradation I (anaerobic)
-
-
P164-PWY
purine nucleobases degradation II (anaerobic)
-
-
PWY-5497
purine ribonucleosides degradation
-
-
PWY0-1296
putrescine biosynthesis III
-
-
PWY-46
putrescine degradation I
-
-
PUTDEG-PWY
putrescine degradation III
-
-
PWY-0
putrescine degradation IV
-
-
PWY-2
putrescine degradation V
-
-
PWY-3
pyridoxal 5'-phosphate biosynthesis I
-
-
PYRIDOXSYN-PWY
pyridoxal 5'-phosphate salvage I
-
-
PLPSAL-PWY
pyridoxal 5'-phosphate salvage II (plants)
-
-
PWY-7204
pyrimidine deoxyribonucleosides degradation
-
-
PWY-7181
pyrimidine deoxyribonucleosides salvage
-
-
PWY-7199
pyrimidine deoxyribonucleotide phosphorylation
-
-
PWY-7197
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
pyrimidine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7184
pyrimidine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7187
pyrimidine deoxyribonucleotides de novo biosynthesis III
-
-
PWY-6545
pyrimidine deoxyribonucleotides de novo biosynthesis IV
-
-
PWY-7198
pyrimidine deoxyribonucleotides dephosphorylation
-
-
PWY-7206
Pyrimidine metabolism
-
-
pyrimidine metabolism
-
-
pyrimidine nucleobases salvage II
-
-
PWY-7194
pyrimidine ribonucleosides degradation
-
-
PWY0-1295
pyrimidine ribonucleosides salvage I
-
-
PWY-7193
pyrimidine ribonucleosides salvage II
-
-
PWY-6556
pyrimidine ribonucleosides salvage III
-
-
PWY-7195
pyruvate decarboxylation to acetyl CoA I
-
-
PYRUVDEHYD-PWY
pyruvate decarboxylation to acetyl CoA II
-
-
PWY-6970
pyruvate decarboxylation to acetyl CoA III
-
-
PWY-8275
pyruvate fermentation to (R)-lactate
-
-
PWY-8274
pyruvate fermentation to (S)-lactate
-
-
PWY-5481
pyruvate fermentation to acetate I
-
-
P142-PWY
pyruvate fermentation to acetate II
-
-
PWY-5482
pyruvate fermentation to acetate III
-
-
PWY-5483
pyruvate fermentation to acetate IV
-
-
PWY-5485
pyruvate fermentation to acetate V
-
-
PWY-5537
pyruvate fermentation to acetate VI
-
-
PWY-5538
pyruvate fermentation to acetate VII
-
-
PWY-5600
pyruvate fermentation to acetate VIII
-
-
PWY-5768
pyruvate fermentation to acetoin III
-
-
PWY3O-440
pyruvate fermentation to acetone
-
-
PWY-6588
pyruvate fermentation to butanoate
-
-
CENTFERM-PWY
pyruvate fermentation to butanol I
-
-
PWY-6583
pyruvate fermentation to butanol II (engineered)
-
-
PWY-6883
pyruvate fermentation to ethanol I
-
-
PWY-5480
pyruvate fermentation to ethanol II
-
-
PWY-5486
pyruvate fermentation to ethanol III
-
-
PWY-6587
pyruvate fermentation to hexanol (engineered)
-
-
PWY-6863
pyruvate fermentation to isobutanol (engineered)
-
-
PWY-7111
pyruvate fermentation to opines
-
-
PWY-7351
pyruvate fermentation to propanoate I
-
-
P108-PWY
quercetin glucoside degradation (Allium)
-
-
PWY-7133
quercetin sulfate biosynthesis
-
-
PWY-6199
queuosine biosynthesis I (de novo)
-
-
PWY-6700
queuosine biosynthesis III (queuosine salvage)
-
-
PWY-8106
quinoxaline-2-carboxylate biosynthesis
-
-
PWY-7734
Rapoport-Luebering glycolytic shunt
-
-
PWY-6405
reactive oxygen species degradation
-
-
DETOX1-PWY-1
reductive acetyl coenzyme A pathway
-
-
reductive acetyl coenzyme A pathway I (homoacetogenic bacteria)
-
-
CODH-PWY
reductive acetyl coenzyme A pathway II (autotrophic methanogens)
-
-
PWY-7784
reductive glycine pathway of autotrophic CO2 fixation
-
-
PWY-8303
reductive monocarboxylic acid cycle
-
-
PWY-5493
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinoate biosynthesis I
-
-
PWY-6872
retinol biosynthesis
-
-
PWY-6857
Riboflavin metabolism
-
-
ricinoleate biosynthesis
-
-
PWY-7618
roseoflavin biosynthesis
-
-
PWY-7863
rosmarinic acid biosynthesis I
-
-
PWY-5048
rosmarinic acid biosynthesis II
-
-
PWY-5049
Rubisco shunt
-
-
PWY-5723
rutin degradation (plants)
-
-
PWY-7134
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis
-
-
PWY-8301
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine degradation
-
-
PWY-8302
S-adenosyl-L-methionine biosynthesis
-
-
SAM-PWY
S-adenosyl-L-methionine salvage I
-
-
PWY-6151
S-adenosyl-L-methionine salvage II
-
-
PWY-5041
S-methyl-5'-thioadenosine degradation II
-
-
PWY-6756
saframycin A biosynthesis
-
-
PWY-7671
salicylate biosynthesis I
-
-
PWY-6406
salicylate biosynthesis II
-
-
PWY-8321
salidroside biosynthesis
-
-
PWY-6802
salinosporamide A biosynthesis
-
-
PWY-6627
Salmonella enterica serotype O:13 O antigen biosynthesis
-
-
PWY-8230
Salmonella enterica serotype O:18 O antigen biosynthesis
-
-
PWY-8206
Salmonella enterica serotype O:39 O antigen biosynthesis
-
-
PWY-8236
Salmonella enterica serotype O:54 O antigen biosynthesis
-
-
PWY-8204
Salmonella enterica serotype O:6,7 O antigen biosynthesis
-
-
PWY-8208
saponin biosynthesis II
-
-
PWY-5756
sciadonate biosynthesis
-
-
PWY-6598
scopoletin biosynthesis
-
-
PWY-6792
secologanin and strictosidine biosynthesis
-
-
PWY-5290
Secondary bile acid biosynthesis
-
-
sedoheptulose bisphosphate bypass
-
-
PWY0-1517
selenate reduction
-
-
PWY-6932
seleno-amino acid biosynthesis (plants)
-
-
PWY-6936
seleno-amino acid detoxification and volatilization I
-
-
PWY-6931
seleno-amino acid detoxification and volatilization III
-
-
PWY-6933
Selenocompound metabolism
-
-
selenocysteine biosynthesis
-
-
serotonin and melatonin biosynthesis
-
-
PWY-6030
serotonin degradation
-
-
PWY-6313
sesamin biosynthesis
-
-
PWY-5469
Sesquiterpenoid and triterpenoid biosynthesis
-
-
Shigella boydii serotype 6 O antigen biosynthesis
-
-
PWY-8232
sitosterol degradation to androstenedione
-
-
PWY-6948
sophorosyloxydocosanoate deacetylation
-
-
SOPHOROSYLOXYDOCOSANOATE-DEG-PWY
sorbitol biosynthesis II
-
-
PWY-5530
sorgoleone biosynthesis
-
-
PWY-5987
spermidine biosynthesis I
-
-
BSUBPOLYAMSYN-PWY
spermidine biosynthesis II
-
-
PWY-6559
spermidine biosynthesis III
-
-
PWY-6834
spermine and spermidine degradation I
-
-
PWY-6117
spermine biosynthesis
-
-
ARGSPECAT-PWY
sphingolipid biosynthesis (mammals)
-
-
PWY-7277
sphingolipid biosynthesis (plants)
-
-
PWY-5129
sphingolipid biosynthesis (yeast)
-
-
SPHINGOLIPID-SYN-PWY
Sphingolipid metabolism
-
-
sphingomyelin metabolism
-
-
PWY3DJ-11281
sphingosine and sphingosine-1-phosphate metabolism
-
-
PWY3DJ-11470
sphingosine metabolism
-
-
Spodoptera littoralis pheromone biosynthesis
-
-
PWY-7656
spongiadioxin C biosynthesis
-
-
PWY-7935
sporopollenin precursors biosynthesis
-
-
PWY-6733
stachyose biosynthesis
-
-
PWY-5337
stachyose degradation
-
-
PWY-6527
Starch and sucrose metabolism
-
-
starch biosynthesis
-
-
PWY-622
starch degradation I
-
-
PWY-842
starch degradation II
-
-
PWY-6724
starch degradation III
-
-
PWY-6731
starch degradation IV
-
-
PWY-6735
starch degradation V
-
-
PWY-6737
stearate biosynthesis I (animals)
-
-
PWY-5972
stearate biosynthesis II (bacteria and plants)
-
-
PWY-5989
stearate biosynthesis III (fungi)
-
-
PWY3O-355
stearate biosynthesis IV
-
-
PWY-8280
stellariose and mediose biosynthesis
-
-
PWY-6525
stellatic acid biosynthesis
-
-
PWY-7736
Steroid hormone biosynthesis
-
-
sterol biosynthesis (methylotrophs)
-
-
PWY-8026
sterol:steryl ester interconversion (yeast)
-
-
PWY-7424
stigma estolide biosynthesis
-
-
PWY-6453
Stilbenoid, diarylheptanoid and gingerol biosynthesis
-
-
streptomycin biosynthesis
-
-
PWY-5940
Streptomycin biosynthesis
-
-
streptorubin B biosynthesis
-
-
PWY1A0-6120
suberin monomers biosynthesis
succinate to chytochrome c oxidase via cytochrome c6
-
-
PWY1YI0-2
succinate to cytochrome bd oxidase electron transfer
-
-
PWY0-1353
succinate to cytochrome bo oxidase electron transfer
-
-
PWY0-1329
succinate to cytochrome c oxidase via plastocyanin
-
-
PWY1YI0-3
succinate to plastoquinol oxidase
-
-
PWY1YI0-8
sucrose biosynthesis I (from photosynthesis)
-
-
SUCSYN-PWY
sucrose biosynthesis II
-
-
PWY-7238
sucrose biosynthesis III
-
-
PWY-7347
sucrose degradation I (sucrose phosphotransferase)
-
-
SUCUTIL-PWY
sucrose degradation II (sucrose synthase)
-
-
PWY-3801
sucrose degradation III (sucrose invertase)
-
-
PWY-621
sucrose degradation IV (sucrose phosphorylase)
-
-
PWY-5384
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
sucrose degradation VII (sucrose 3-dehydrogenase)
-
-
SUCROSEUTIL2-PWY
sulfate activation for sulfonation
-
-
PWY-5340
sulfated glycosaminoglycan metabolism
-
-
sulfide oxidation IV (mitochondria)
-
-
PWY-7927
sulfite oxidation II
-
-
PWY-5279
sulfite oxidation III
-
-
PWY-5278
sulfite oxidation IV (sulfite oxidase)
-
-
PWY-5326
sulfoacetaldehyde degradation I
-
-
PWY-1281
sulfolactate degradation II
-
-
PWY-6637
sulfolactate degradation III
-
-
PWY-6638
sulfopterin metabolism
-
-
sulfur volatiles biosynthesis
-
-
PWY-6736
superoxide radicals degradation
-
-
DETOX1-PWY
superpathway of (Kdo)2-lipid A biosynthesis
-
-
KDO-NAGLIPASYN-PWY
superpathway of 5-aminoimidazole ribonucleotide biosynthesis
-
-
PWY-6277
superpathway of adenosylcobalamin salvage from cobinamide I
-
-
COBALSYN-PWY
superpathway of adenosylcobalamin salvage from cobinamide II
-
-
PWY-6269
superpathway of coenzyme A biosynthesis III (mammals)
-
-
COA-PWY-1
superpathway of fatty acid biosynthesis initiation
-
-
FASYN-INITIAL-PWY
superpathway of fermentation (Chlamydomonas reinhardtii)
-
-
PWY4LZ-257
superpathway of glucose and xylose degradation
-
-
PWY-6901
superpathway of glycolysis and the Entner-Doudoroff pathway
-
-
GLYCOLYSIS-E-D
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass
-
-
GLYCOLYSIS-TCA-GLYOX-BYPASS
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of L-aspartate and L-asparagine biosynthesis
-
-
ASPASN-PWY
superpathway of methylsalicylate metabolism
-
-
PWY18C3-25
superpathway of nicotine biosynthesis
-
-
PWY-7342
superpathway of ornithine degradation
-
-
ORNDEG-PWY
superpathway of phospholipid biosynthesis II (plants)
-
-
PHOSLIPSYN2-PWY
superpathway of photosynthetic hydrogen production
-
-
PWY-7731
superpathway of polyamine biosynthesis II
-
-
POLYAMINSYN3-PWY
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
-
-
PWY0-166
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis
-
-
PWY-7328
superpathway of UDP-N-acetylglucosamine-derived O-antigen building blocks biosynthesis
-
-
PWY-7332
syringate degradation
-
-
PWY-6339
Taurine and hypotaurine metabolism
-
-
taurine biosynthesis I
-
-
PWY-5331
taurine biosynthesis II
-
-
PWY-7850
taurine biosynthesis III
-
-
PWY-8359
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VI (Helicobacter)
-
-
REDCITCYC
TCA cycle VII (acetate-producers)
-
-
PWY-7254
TCA cycle VIII (Chlamydia)
-
-
TCA-1
tea aroma glycosidic precursor bioactivation
-
-
PWY-7114
teichoic acid biosynthesis
-
-
teichuronic acid biosynthesis (B. subtilis 168)
-
-
PWY-7820
terminal O-glycans residues modification (via type 2 precursor disaccharide)
-
-
PWY-7434
Terpenoid backbone biosynthesis
-
-
testosterone and androsterone degradation to androstendione (aerobic)
-
-
PWY-6943
tetracenomycin C biosynthesis
-
-
PWY-7485
tetradecanoate biosynthesis (mitochondria)
-
-
PWY66-430
tetrahydrofolate biosynthesis I
-
-
PWY-6614
tetrahydrofolate biosynthesis II
-
-
PWY2DNV-11
tetrahydrofolate metabolism
-
-
tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate
-
-
PWY-6613
tetrahydromonapterin biosynthesis
-
-
PWY0-1433
tetrahydropteridine recycling
-
-
PWY-8099
tetrahydroxyxanthone biosynthesis (from benzoate)
-
-
PWY-5001
tetrapyrrole biosynthesis I (from glutamate)
-
-
PWY-5188
tetrapyrrole biosynthesis II (from glycine)
-
-
PWY-5189
the visual cycle I (vertebrates)
-
-
PWY-6861
theobromine biosynthesis I
-
-
PWY-5039
theophylline degradation
-
-
PWY-6999
thiamine diphosphate biosynthesis I (E. coli)
-
-
PWY-6894
thiamine diphosphate biosynthesis II (Bacillus)
-
-
PWY-6893
thiamine diphosphate biosynthesis III (Staphylococcus)
-
-
PWY-6907
thiamine diphosphate biosynthesis IV (eukaryotes)
-
-
PWY-6908
thiamine diphosphate salvage I
-
-
PWY-6896
thiamine diphosphate salvage II
-
-
PWY-6897
thiamine diphosphate salvage III
-
-
PWY-6898
thiamine diphosphate salvage IV (yeast)
-
-
PWY-7356
thiamine phosphate formation from pyrithiamine and oxythiamine (yeast)
-
-
PWY-7357
thiamine triphosphate metabolism
-
-
PWY-7369
thiazole component of thiamine diphosphate biosynthesis I
-
-
PWY-6892
thioredoxin pathway
-
-
THIOREDOX-PWY
thiosulfate disproportionation IV (rhodanese)
-
-
PWY-5350
threo-tetrahydrobiopterin biosynthesis
-
-
PWY-6983
thymine degradation
-
-
PWY-6430
thyroid hormone biosynthesis
thyroid hormone metabolism I (via deiodination)
-
-
PWY-6260
thyroid hormone metabolism II (via conjugation and/or degradation)
-
-
PWY-6261
toluene degradation II (aerobic) (via 4-methylcatechol)
-
-
TOLUENE-DEG-3-OH-PWY
toluene degradation to 2-hydroxypentadienoate (via toluene-cis-diol)
-
-
TOLUENE-DEG-DIOL-PWY
toluene degradation to 2-hydroxypentadienoate I (via o-cresol)
-
-
TOLUENE-DEG-2-OH-PWY
trans, trans-farnesyl diphosphate biosynthesis
-
-
PWY-5123
trans-3-hydroxy-L-proline degradation
-
-
PWY-7515
trans-4-hydroxy-L-proline degradation I
-
-
HYDROXYPRODEG-PWY
traumatin and (Z)-3-hexen-1-yl acetate biosynthesis
-
-
PWY-5410
trehalose biosynthesis IV
-
-
PWY-2622
trehalose biosynthesis V
-
-
PWY-2661
trehalose degradation I (low osmolarity)
-
-
TREDEGLOW-PWY
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation IV
-
-
PWY-2722
trehalose degradation V
-
-
PWY-2723
trehalose degradation VI (periplasmic)
-
-
PWY0-1466
triacylglycerol degradation
-
-
LIPAS-PWY
trimethylamine degradation
-
-
PWY-6968
trimethylamine N-oxide biosynthesis
-
-
PWY-8292
tRNA charging
-
-
TRNA-CHARGING-PWY
tRNA processing
-
-
PWY0-1479
tRNA splicing I
-
-
PWY-6689
tRNA splicing II
-
-
PWY-7803
tRNA-uridine 2-thiolation and selenation (bacteria)
-
-
PWY-7892
tropane alkaloids biosynthesis
-
-
PWY-5317
Tropane, piperidine and pyridine alkaloid biosynthesis
-
-
Tryptophan metabolism
-
-
tryptophan metabolism
-
-
tunicamycin biosynthesis
-
-
PWY-7821
type I lipoteichoic acid biosynthesis (S. aureus)
-
-
PWY-7817
type IV lipoteichoic acid biosynthesis (S. pneumoniae)
-
-
PWY-7818
ubiquinol-10 biosynthesis (late decarboxylation)
-
-
PWY-5872
Ubiquinone and other terpenoid-quinone biosynthesis
-
-
UDP-alpha-D-galactofuranose biosynthesis
-
-
PWY-7622
UDP-alpha-D-galactose biosynthesis
-
-
PWY-7344
UDP-alpha-D-glucose biosynthesis
-
-
PWY-7343
UDP-alpha-D-glucuronate biosynthesis (from myo-inositol)
-
-
PWY-4841
UDP-alpha-D-glucuronate biosynthesis (from UDP-glucose)
-
-
PWY-7346
UDP-GlcNAc biosynthesis
-
-
UDP-N-acetyl-beta-L-fucosamine biosynthesis
-
-
PWY-7330
UDP-N-acetyl-beta-L-quinovosamine biosynthesis
-
-
PWY-7331
UDP-N-acetyl-D-galactosamine biosynthesis I
-
-
PWY-5512
UDP-N-acetyl-D-galactosamine biosynthesis II
-
-
PWY-5514
UDP-N-acetyl-D-galactosamine biosynthesis III
-
-
PWY-8013
UDP-N-acetyl-D-glucosamine biosynthesis I
-
-
UDPNAGSYN-PWY
UDP-N-acetyl-D-glucosamine biosynthesis II
-
-
UDPNACETYLGALSYN-PWY
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing)
-
-
PWY-6387
UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing)
-
-
PWY-6386
UDP-N-acetylmuramoyl-pentapeptide biosynthesis III (meso-diaminopimelate containing)
-
-
PWY-7953
ultra-long-chain fatty acid biosynthesis
-
-
PWY-8041
UMP biosynthesis I
-
-
PWY-5686
UMP biosynthesis II
-
-
PWY-7790
UMP biosynthesis III
-
-
PWY-7791
uracil degradation I (reductive)
-
-
PWY-3982
urate conversion to allantoin I
-
-
PWY-5691
urate conversion to allantoin II
-
-
PWY-7394
urate conversion to allantoin III
-
-
PWY-7849
urea degradation II
-
-
PWY-5704
UTP and CTP de novo biosynthesis
-
-
PWY-7176
UTP and CTP dephosphorylation I
-
-
PWY-7185
UTP and CTP dephosphorylation II
-
-
PWY-7177
Valine, leucine and isoleucine biosynthesis
-
-
Valine, leucine and isoleucine degradation
-
-
valproate beta-oxidation
-
-
PWY-8182
vancomycin resistance I
-
-
PWY-6454
vancomycin resistance II
-
-
PWY-6455
vanillin biosynthesis I
-
-
PWY-5665
Various types of N-glycan biosynthesis
-
-
vernolate biosynthesis III
-
-
PWY-6917
very long chain fatty acid biosynthesis I
-
-
PWY-5080
very long chain fatty acid biosynthesis II
-
-
PWY-7036
viridicatumtoxin biosynthesis
-
-
PWY-7659
vitamin B1 metabolism
-
-
vitamin B12 metabolism
-
-
Vitamin B6 metabolism
-
-
vitamin B6 metabolism
-
-
vitamin D3 biosynthesis
-
-
PWY-6076
vitamin D3 metabolism
-
-
vitamin E biosynthesis (tocopherols)
-
-
PWY-1422
volatile benzenoid biosynthesis I (ester formation)
-
-
PWY-4203
volatile esters biosynthesis (during fruit ripening)
-
-
PWY-6801
wax esters biosynthesis I
-
-
PWY-5884
wax esters biosynthesis II
-
-
PWY-5885
xanthine and xanthosine salvage
-
-
SALVPURINE2-PWY
xanthohumol biosynthesis
-
-
PWY-5135
xanthommatin biosynthesis
-
-
PWY-8249
xylitol degradation I
-
-
LARABITOLUTIL-PWY
xyloglucan degradation II (exoglucanase)
-
-
PWY-6807
zymosterol biosynthesis
-
-
PWY-6074
[2Fe-2S] iron-sulfur cluster biosynthesis
-
-
PWY-7250
(5R)-carbapenem carboxylate biosynthesis
-
-
PWY-5737
(5R)-carbapenem carboxylate biosynthesis
-
-
4-hydroxymandelate degradation
-
-
4-HYDROXYMANDELATE-DEGRADATION-PWY
4-hydroxymandelate degradation
-
-
4-hydroxyphenylacetate degradation
-
-
3-HYDROXYPHENYLACETATE-DEGRADATION-PWY
4-hydroxyphenylacetate degradation
-
-
adipate degradation
-
-
PWY-8354
bile acid biosynthesis, neutral pathway
-
-
PWY-6061
bile acid biosynthesis, neutral pathway
-
-
catecholamine biosynthesis
-
-
PWY66-301
catecholamine biosynthesis
-
-
cis-vaccenate biosynthesis
-
-
PWY-5973
cis-vaccenate biosynthesis
-
-
cyanate degradation
-
-
CYANCAT-PWY
cyclohexanol degradation
-
-
CYCLOHEXANOL-OXIDATION-PWY
cyclohexanol degradation
-
-
dolichol and dolichyl phosphate biosynthesis
-
-
PWY-6129
dolichol and dolichyl phosphate biosynthesis
-
-
enterobactin biosynthesis
-
-
ENTBACSYN-PWY
enterobactin biosynthesis
-
-
folate polyglutamylation
-
-
PWY-2161
folate polyglutamylation
-
-
methylaspartate cycle
-
-
PWY-6728
methylaspartate cycle
-
-
morphine biosynthesis
-
-
PWY-5270
morphine biosynthesis
-
-
myo-inositol biosynthesis
-
-
PWY-2301
myo-inositol biosynthesis
-
-
octane oxidation
-
-
P221-PWY
phenylmercury acetate degradation
-
-
P641-PWY
phenylmercury acetate degradation
-
-
suberin monomers biosynthesis
-
-
PWY-1121
suberin monomers biosynthesis
-
-
thyroid hormone biosynthesis
-
-
PWY-6241
thyroid hormone biosynthesis
-
-
urea cycle
-
-
PWY-4984
vitamin K-epoxide cycle
-
-
PWY-7999
vitamin K-epoxide cycle
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
endothelial cells, subunit MYPT1
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
explant culture, stimulation with retinoic acid, interleukin-1 or tumour necrosis factor induces aggrecanase activity
brenda
-
brenda
-
WT51 cell, EBV-transformed
brenda
-
both the neuronal and the extraneuronal AADC mRNA isoforms are present at early brain developmental stages in the basal ganglia
brenda
-
muscle LAP maintains LAP activitity all through Jinhua ham processing. Muscle LAP may play the most important role in generating free amino acids during the processing of Jinhua ham
brenda
-
brenda
-
bound to
brenda
-
3029, 391914, 391915, 391916, 391932, 653977, 661953, 667149, 705297, 735978, 736152, 744744
brenda
-
-
brenda
-
lung endothelium
brenda
-
lung blood vessels
brenda
-
-
brenda
-
-
brenda
-
in healthy animals, 5-LOX expression is almost exclusively limited to the bronchiolar epithelial cells, while Metastrongylus spp.-parasitized pigs have greater 5-LOX-specific immunoreactivity involving a wide range of cell types within foci of granulomatous and eosinophilic bronchopneumonia
brenda
-
-
brenda
-
i.e. C2Bbe1 cell
brenda
-
brenda
-
-
brenda
-
ketohexokinase protein is detected in the trophectoderm at day 11 of pregnancy
brenda
-
expressed by areolae of the chorionic epithelium
brenda
-
-
brenda
-
-
brenda
-
-
brenda
peri- and postimplantation conceptus. Prostaglandin H synthase and prostaglandin E synthase are down-regulated, and prostaglandin G synthase, prostaglandin F synthase and carbonyl reductase/prostaglandin 9-reductase are down-regulated in conceptuses during trophoblasic elongation. After initiation of implantation, expression of prostaglandin G synthase, prostaglandin F synthase and carbonyl reductase/prostaglandin 9-reductase in conceptuses increases and remains higher until days 24-25 of pregnancy
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
presence of 11beta-hydroxysteroid dehydrogenase mRNA transcripts and protein in all tissues of the reproductive tract examined, but cortison-cortisol interconversion is undetectable in the corpus and cauda epididymides, vas deferens, vesicular and prostate glands
brenda
-
different types
brenda
-
ovarian cyst
brenda
-
resting and maturing
brenda
-
brenda
-
KLK4 endometrial mRNA expression is greatest on days 0, 5, and 10 when compared with days 12, 15, and 17 of the estrous cycle and greater in cyclic compared with pregnant gilts
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
20% of the activity in grey matter
brenda
-
-
brenda
-
ganglion cells of Auerbachs plexus
brenda
-
-
brenda
-
-
brenda
-
brenda
-
brenda
-
parotid glands
brenda
-
-
brenda
-
-
brenda
-
granulosa cells, Leydig cells and Sertoli cells
brenda
-
cortisol oxidation increases threefold with antral follicle diameter, accompanied by threefold increase in 11beta-hydroxysteroid dehydrogenase activity. Neither intact cells nor homogenates display net 11-ketosteroid reductase activities. Intact granulosa cells from ovarian cysts exhibit significantly lower enzyme activities than cells from large antral follicles
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
162% of activity of renal cortex
brenda
-
low activity
brenda
-
-
brenda
-
-
brenda
-
fetal absorptive intestinal epithelium
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
lymphocytes
brenda
-
-
brenda
-
LLC-PK1 renal tubule cell line expressing the Rattus norvegicus glucocorticoid receptor GR
brenda
-
-
brenda
-
-
brenda
-
-
brenda
high expression level of ADSS2 mRNA
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
leptin decreases creatibe kinase
brenda
-
cardiac myocytes isolated from failing hearts
brenda
-
-
brenda
-
synaptosome from brain cortex
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
81211, 81216, 81263, 81282, 95365, 95367, 394577, 438003, 438006, 438010, 438024, 486989, 486991, 486995, 695200, 697453, 701342, 712899
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
primary preadipocytes
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
the salivary levels of adenosine deaminase activity are significantly elevated in animals with local inflammation, gastrointestinal disorder and respiratory disorder
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
UCHL3
brenda
-
-
brenda
-
-
brenda
-
extensive threonine utilization
brenda
-
2412, 3296, 3300, 3302, 95776, 95777, 95798, 639313, 639318, 639319, 639329, 639333, 645262, 647492, 683344, 745248, 745249, 745253
brenda
-
-
brenda
-
ATCC, CRL-1746
brenda
-
isoform I
brenda
isoform PMCA 4 is more abundant in the cerebrum than in the cerebellum
brenda
-
-
brenda
-
expression of isoform HAS1 in theca cells of healthy and early atretic follicles of stage I and stage II and in progressing atretic stage III follicles
brenda
-
brenda
-
a variety of mammalian cell lines in tissue culture
brenda
-
brenda
oropharyngeal tonsil
brenda
unerupted, incisor
brenda
-
-
brenda
-
maxillary and mandibular second molars from six month old pigs
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
ketohexokinase protein is detected at all stages of gestation studied through day 85
brenda
-
the enzyme is mainly localized in the trophoblast villus in the placenta on day 30 of pregnancy
brenda
cortical renal TEC
brenda
-
-
brenda
-
low activity
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
portal drained viscera, PDV
brenda
-
-
brenda
-
ATGL expression increases dramatically in the subcutaneous adipose during adipose development and maturation, as well as during in vitro adipogenesis. Within the white adipose tissue, ATGL is expressed at higher levels in the adipocyte than in the stromal-vascular fraction
brenda
-
PGDH messenger RNA (mRNA) abundance decreases significantly in the visceral yolk sac membrane and the amnion throughout the last third of pregnancy
brenda
-
-
brenda
-
hormone-sensitive lipase, lipolysis of storage triacylglycerides
brenda
-
brenda
-
a reduced protein diet does not change protein expression and activity in subcutaneous adipose tissue
brenda
both subcutaneous fat content and intramusclular fat content are higher in obese than in lean pigs. MAT2beta mRNA abundance is lower in both subcutaneous adipose tissue and skeletal muscle in obese pigs compared with lean pigs
brenda
higher expression level
brenda
-
increase in expression with growth stage, higher expression in muscle than in adipose tissue
brenda
regulatory subunit MAT2beta is expressed at a higher level in liver and duodenum, followed by the stomach, fat and longissinus dorsi muscle
brenda
subcutaneous, expression of GYS2
brenda
subcutaneous, GYS1
brenda
subcutaneous, high expression level
brenda
SULT2A1
brenda
-
-
81631, 285990, 287528, 390141, 637814, 648740, 648745, 688147, 718751, 725447, 762367
brenda
-
isoform I
brenda
-
little lyase activity
brenda
-
low activity
brenda
-
-
brenda
-
parathyroid hormone increases CYP1alpha mRNA and protein in a time-dependent manner. H2O2 inhibits parathyroid hormone-stimulated CYP1alpha protein levels and 1,25(OH)2D production in a dose dependent manner. The catalytic activity of the CYP1alpha protein may be reduced by free radical damage in CYP27B1 cells
brenda
-
3200, 37458, 37462, 37463, 37466, 37467, 37470, 37475, 286124, 489479, 637818, 641674, 642371, 643065, 645224, 645351, 645353, 668729, 675286, 691656, 704517, 741864, 762703
brenda
aortic endothelial cells
brenda
-
endothelial cells
brenda
high expression of SMS1 mRNA
brenda
-
intimal layer
brenda
-
smooth muscle
brenda
-
coronary arteriole
brenda
-
coronary arteriole, enzyme activity increases twofold with hypertension. Inhibition of enzyme activity by Nomega-hydroxy-nor-L-arginine or incubation with L-arginine partially restores NO release and dilation to adenosine in hypertrophic vessels
brenda
-
coronary artery
brenda
-
coronary artery smooth muscle
brenda
-
porcine coronary artery endothelial cell, PCAEC. Exposure of cells to hypoxia for 2 h followed by 1 h of reoxygenation significantly increases reactive oxygen species formation. Pretreatment with the NADPH oxidase inhibitors, diphenyleneiodonium and apocynin , significantly attenuates hypoxia/reoxygenation-induced reactive oxygen species formation. Exposure of PCAECs to hypoxia/reoxygenation causes a significant increase in serine-threonine kinase Akt and ERK1/2 activation. Exposure of PCAEC spheroids to hypoxia/reoxygenation significantly increases endothelial spheroid sprouting, whereas pharmacological inhibition of NADPH oxidase or genetic deletion of the NADPH oxidase subunit, p47phox (p47phox/), significantly suppresses these changes
brenda
-
pulmonary
brenda
-
pulmonary, cultured model
brenda
-
vascular
brenda
-
-
brenda
-
immature B-lineage cell
brenda
-
brenda
high expression
brenda
high expression level
brenda
-
SMPP-1M
brenda
-
2654, 286014, 438003, 438006, 438011, 438024, 438025, 485965, 649014, 650933, 677083, 683296, 697453, 705297, 714572, 718751
brenda
-
cellular suppression of TNF-alpha is measured using human whole blood (WBA) stimulated with lipopolysaccharide (LPS)
brenda
-
red blood cells
brenda
-
serum, plasma, leukocytes
brenda
A9CQL8, F1RPC8, O02705, P23687, P79282, P80147, Q02038, Q2TJA5, Q6Q2J0, Q9MYU4, Q9TUI8
-
1166, 1167, 1168, 1172, 1173, 1177, 1180, 1183, 1184, 1712, 3975, 3989, 3991, 3995, 4222, 4257, 33629, 33638, 35955, 36195, 37053, 37062, 37075, 37084, 37496, 37498, 81015, 81359, 81634, 81643, 114244, 134922, 135380, 135418, 135448, 137041, 137060, 137176, 170958, 171148, 171928, 171935, 171965, 208983, 209000, 209001, 209002, 209010, 209018, 209381, 209387, 209392, 209393, 209775, 210150, 246781, 246800, 286166, 286168, 286172, 286174, 286176, 286177, 286178, 286181, 286182, 286217, 287017, 287526, 287528, 287802, 287806, 287809, 287812, 288156, 288163, 347824, 347825, 347826, 389564, 391541, 391626, 391875, 393686, 393971, 393993, 394000, 394549, 394559, 394867, 438244, 440199, 440211, 485965, 485967, 485968, 485971, 487281, 487348, 488430, 489215, 489305, 489333, 489334, 489335, 489336, 489339, 489404, 491403, 637033, 637036, 637038, 637048, 637058, 637073, 637075, 637076, 637081, 637814, 639997, 640009, 640353, 640370, 640378, 640632, 640659, 641418, 641674, 641693, 642371, 642558, 642636, 642661, 642688, 642697, 642704, 642751, 643065, 644092, 644200, 644883, 645157, 645255, 645979, 646118, 646167, 646384, 646429, 647283, 647285, 647286, 650529, 652103, 652324, 652332, 652483, 652739, 652752, 653194, 653281, 653873, 655198, 655232, 655982, 660669, 661332, 661446, 661605, 664179, 664389, 665443, 665849, 667797, 668606, 668828, 669164, 669781, 669849, 671335, 672536, 675313, 678539, 680549, 683228, 683344, 683389, 683962, 684045, 685115, 685683, 686040, 686194, 687797, 688271, 688712, 689743, 690084, 690846, 692312, 697453, 699163, 699830, 702437, 704363, 705297, 705906, 709617, 710367, 712890, 712902, 714142, 718096, 721520, 721841, 721847, 724252, 730996, 733253, 734298, 738454, 741580, 742559, 743355, 753537, 754898, 759407
brenda
-
AADC expression in the developing pig brain is highly expressed in the basal ganglia and the brain stem regions, and also significantly expressed in the cortex, the hippocampus and the cerebellum
brenda
-
both full length enzyme and a shorter form with aminoterminal deletion
brenda
-
C4ST-1 and C4ST-2 are ubiquitously expressed in the postnatal mouse brain, tissue distribution of expression, overview
brenda
-
cerebellum
brenda
-
cerebral cortex
brenda
-
cerebral hemispheres
brenda
-
cerebrum, cerebellum, medulla
brenda
contains a skeletal muscle type and heart type mixed heterotetrameric enzyme, H2M2
brenda
-
corpus striatum and globus pallidus
brenda
-
cortex
brenda
-
distribution in brain
brenda
dopamine-producing cells in the substantia nigra
brenda
-
endothelial cells, synaptic membranes of astro- and pericytes
brenda
GYS1
brenda
high expression
brenda
highest activity
brenda
-
hypothalamus
brenda
-
increase of AADC activity with brain development is considered to be associated with special stages of neuronal maturation and tissue differentiation
brenda
-
induction of lateral fluid percussion brain injury results in up-regulation of uPA and ERK mitogen-activated protein kinase. uPA contributes to the impairment of sodium nitroprusside and PGE2-mediated cerebrovasodilatation through activation of low-density lipoprotein receptor and ERK mitogen-activated protein kinase
brenda
-
isoform I
brenda
-
low activity
brenda
low level
brenda
-
medulla, paracortex, cortex
brenda
-
midbrain
brenda
-
pericyte
brenda
-
pial membranes associated with brain and spinal cord
brenda
preferentially expressed in brain, transcripts in the hippocampus, cerebral cortex, and the granular cell layer of the cerebellum
brenda
-
presence of 2 isoforms
brenda
-
striatum
brenda
-
striatum, 2 enzyme forms: MW 170000 Da and MW 180000 Da
brenda
-
synaptic membranes
brenda
the activity increases in the acute phase after hypoxia in the brain of piglets
brenda
-
white glial-enriched matter and grey neuronal-enriched matter
brenda
-
-
brenda
-
both the neuronal and the extraneuronal AADC mRNA isoforms are present at early brain developmental stages in the brain stem
brenda
-
-
brenda
-
GPx is detected on the membranes of vacuoles situated in the gland's epithelial cells
brenda
-
pronounced 11beta-hydroxysteroid dehydrogenase activity in presence of NADP+ and NAD+
brenda
-
strongest expression of isoform SPCA2
brenda
-
-
brenda
-
pronounced 11beta-hydroxysteroid dehydrogenase activity in presence of NADP+ and NAD+
brenda
-
weak enzyme expression
brenda
-
-
brenda
-
smooth muscle
brenda
-
-
brenda
-
elastin, commercial product
brenda
-
presence of 11beta-hydroxysteroid dehydrogenase mRNA transcripts and protein in all tissues of the reproductive tract examined, but cortison-cortisol interconversion is undetectable in the corpus and cauda epididymides, vas deferens, vesicular and prostate glands
brenda
-
weak enzyme expression
brenda
-
brenda
-
high expression
brenda
high expression of SMS1 mRNA
brenda
-
low activity
brenda
-
brenda
-
endothelial cells
brenda
-
brenda
and longissimus dorsi muscle, similar expression pattern that is at a low level at birth and increasing with aging to the highest level at postnatal day 8 in longissinus doris muscle and postnatal day 14 in cerebrum. Weaning decreases the expression level of the GPD1 gene
brenda
isoform PMCA 2 is more abundant in the cerebellum than in the cerebrum
brenda
low SMS1 expression level
brenda
-
-
brenda
-
mitochondrial fraction of cerebral tissue, hypoxia-treated, classified into a normoxic group and a hypoxic group
brenda
-
of newborn piglet
brenda
-
of newborn piglets
brenda
-
brenda
low expression level
brenda
moderate expression of SMS1 mRNA
brenda
very low expression level
brenda
-
-
brenda
-
from articular cartilage
brenda
-
3165, 488370, 638139, 638281, 697453, 699163, 711142, 713952, 718751, 753801, 762703
brenda
-
HMT activity comparable to activity in the jejunum
brenda
-
low activity
brenda
low SMS1 expression level
brenda
-
moderate activity
brenda
-
sigmoidal colon, high expression
brenda
weak expression of SMS1 mRNA
brenda
-
36734, 651057, 652745, 658231, 658431, 658742, 659167, 667691, 685330, 686014, 697313, 706963, 709193, 710778, 711325, 711489, 711909, 712915, 715610, 731969, 732930, 740359, 743564, 749562, 750445, 751162, 751273
brenda
-
from heart
brenda
from intestine
brenda
-
from kideney
brenda
-
from kidney
brenda
-
from kidney, isozyme ERAP1
brenda
from pancreas
brenda
from porcine pancreas
brenda
-
highly purified pancreatic lipase
brenda
-
pancreatic alpha-amylase
brenda
-
purified enzyme
brenda
-
purified kidney enzyme
brenda
-
various commercial preparations from pancreas and pure enzyme
brenda
-
brenda
at days 12-14 of pregnancy and the estrous cycle, the expression of prostaglandin E2 synthase, prostaglandin F synthase, and carbonyl reductase/prostaglandin 9-ketoreductase genes and prostaglandin E2 synthase/prostaglandin F synthase ratio are significantly higher in corpora lutea of the pregnant gilts compared to the corpora lutea from the parallel ovaries of the cyclic gilts. There is no difference in expression of prostaglandin E2 synthase, prostaglandin F synthase, and carbonyl reductase/prostaglandin 9-ketoreductase genes and prostaglandin E2 synthase/prostaglandin F synthase ratio between corpora lutea ipsi- and contralateral to the uterine horn with the developing embryos
brenda
-
at early and mid pregnancy up to 71 days, 3beta-hydroxysteroid dehydrogenase protein is observed in large luteal cells, while on day 71, the enzyme is present exclusively in small luteal cells. Enzyme mRNA is detected in all investigated samples isolated at different stages of pregnancy
brenda
-
cell culture
brenda
expression of CBR1 mRNA and protein is constant during the cycle and pregnancy
brenda
-
expression of mRNA for 11beta-hydroxysteroid dehydrogenase type 1, 11beta-hydroxysteroid dehydrogenase type 2 and for glucocorticoid receptor during the estrous cycle. Level of 11beta-hydroxysteroid dehydrogenase type 1 mRNA is higher at the regressed state than at the other stages, whereas level of 11beta-hydroxysteroid dehydrogenase type 2 mRNA is lower at the regressed stage than at the other stages
brenda
high expression level of the lung-type and the microsomal endometrium-type isozymes
brenda
highest abundance of the protein
brenda
-
highest expression. In pigs, isoform MAP3K8 expression is higher in mature corpus luteums (or those of the mid-luteal phase) than in regressing corpus luteums (late luteal phase)
brenda
histone H3-K4 demethylase is restricted to the corpus luteum
brenda
-
MTE-II is strongly upregulated in corpus luteum during pregnancy
brenda
-
brenda
-
low activity
brenda
-
-
brenda
-
4% of activity of renal cortex
brenda
-
95270, 95565, 95573, 95574, 95575, 210149, 210150, 393272, 668729, 697453, 718751
brenda
high expression level
brenda
-
L-CPT I
brenda
-
low activity
brenda
moderate expression of SMS1 mRNA
brenda
mRNA is abundant in the spleen, duodenum, jejunum, and ileum
brenda
-
mucosa
brenda
regulatory subunit MAT2beta is expressed at a higher level in liver and duodenum, followed by the stomach, fat and longissinus dorsi muscle
brenda
-
brenda
intermediate abundance of the protein
brenda
-
from the hard enamel of developing pig teeth
brenda
-
secretory stage
brenda
transition-stage developing matrix
brenda
-
Enamel formation progresses through a secretory and a maturation stage, MMP-20 is expressed during the secretory and early-maturation stages
brenda
-
MMP-20 is expressed in the secretory stage
brenda
-
-
brenda
from cyclic and pregnant animals, high expression level of the microsomal endometrium-type isozyme, spatiotemporal expression during estrous cycle and early pregnancy
brenda
-
primary
brenda
-
brenda
aortic
brenda
-
from aorta
brenda
from aorta thoracica, subunit MYPT1
brenda
-
of pulmonary arteries, veins, airway epithelium, and nerves
brenda
-
-
brenda
-
isoform III
brenda
-
lung, uterus, stomach
brenda
AF415202
primary and permanent, aortic
brenda
-
brenda
-
LPH activity to gene expression ratio is lower in pigs conventionalized with faecal bacteria or monoassociatied with Escherichia coli compared with germfree pigs. LPH activity to gene expression ratio in pigs monoassociatied with Lactobacillus fermentum is similar to germfree pigs whereas in pigs monoassociatied with Lactobacillus fermentum and contaminated with Klebsiella pneumoniae the ratio is similar to pigs monoassociatied with Escherichia coli
brenda
-
-
brenda
-
cauda epididymis
brenda
-
lowest expression
brenda
SULT2A1 expression is virtually confined to the body in the epididymis. The enzyme is secreted into the ductal lumen via an apocrine mechanism. In addition to the ductal epithelium, immunostaining is observed in spherical particles situated in the ductal lumen and in vascular endothelial cells of the epididymal connective tissue
brenda
SULT2B1 expression is increased significantly along the epididymis, coexpression with HSD3B1. The enzyme is secreted into the ductal lumen via an apocrine mechanism. Immunolocalization study of SULT2B1. SULT2B1-mRNA expression is highest in the distal part of the epididymal tail in muscular cells
brenda
-
-
brenda
-
of pulmonary capillaries
brenda
-
of several tissues including stomach, intestine, colon, prostate glands, and endometrium
brenda
-
primary
brenda
-
brenda
of enamel organ
brenda
-
2624, 37413, 37425, 37430, 37439, 37446, 134945, 286014, 394708, 394721, 394722, 394749, 485965, 489654, 643983, 643994, 647143, 677083, 695200, 708892, 710622, 716958, 725721, 730995, 730996, 735978, 736152, 740001, 744744
brenda
-
hexokinase types II and III, hexokinase III is the predominant form in adult pig erythrocytes, hexokinase II in newborn pig erythrocytes
brenda
-
low activity
brenda
-
mature
brenda
-
brenda
-
anterior segment
brenda
-
highest cystathionine beta-synthase protein presence in cornea, conjunctiva and iris, followed by retina and optic nerve. Cystathionine beta-synthase may be a oxidative defense enzyme in the eye tissue, in particular in the segments of the eye where constant environmental oxidative stress is imposed
brenda
-
porcine trabecular meshwork cells, freshly isolated, and organ culture
brenda
-
vitreous body
brenda
-
vitreous body, retina and ciliary body. Counterbalancing interaction of ACE1 (EC 3.4.15.1) and ACE2 in physiological regulation of ocular circulation and pressure and possible protective role in certain ophthalmic disorders such as glaucoma and diabetic retinopathy
brenda
-
-
brenda
-
low BHMT activity is detected in the G30 fetus, and slightly increased levels of activity are observed in the liver from G45 and G90 fetuses
brenda
-
small intestine
brenda
-
cultured from ear skin biopsies
brenda
primary kidney fibroblast
brenda
-
mucosal epithelial cells and endothelium of intramural vessels of, all intrinsic nerve cell bodies of both submucous and myenteric plexuses
brenda
-
tubulovesicle membranes, H+,K+-ATPase is the most representative protein with 85%
brenda
-
35005, 36729, 94397, 95814, 393709, 488370, 637988, 638138, 638281, 672636, 686551, 711245, 734279, 751533, 753632, 753865, 754466, 755370, 755572
brenda
-
antral mucosa
brenda
-
dIGnT
brenda
-
multiple isoforms
brenda
-
production of pepsinogen
brenda
-
-
brenda
SETDB1 is strongly localized in gonocytes
brenda
-
brenda
high expression
brenda
A4Z6H0, A4Z6H1, A9CQL8, B1PZW5, C1IHT9, O19069, P00889, P09623, P33198, Q29551, Q2TJA5, Q6RHW2, Q6RHW3, Q6RHW4, Q6Y0X5, Q8WNV7, Q9MYU4
-
785, 789, 793, 799, 2960, 3014, 3248, 4408, 5367, 5866, 5868, 5869, 33352, 33713, 33728, 33745, 33750, 33752, 33753, 33755, 33759, 33760, 33761, 33784, 33789, 33796, 33798, 33801, 33802, 33805, 33813, 37496, 81013, 94883, 94890, 94892, 94894, 94903, 94904, 134602, 134645, 171917, 171965, 207967, 209690, 209711, 210150, 210245, 210249, 210264, 210868, 246781, 246800, 246962, 285918, 286168, 286182, 286549, 286555, 286596, 286598, 286606, 286607, 286608, 286609, 286610, 286611, 286626, 286629, 286630, 286632, 286633, 286636, 286637, 286638, 286639, 286640, 286641, 286645, 286646, 286647, 286650, 286651, 286658, 286660, 286661, 286662, 286664, 286665, 286672, 286673, 286674, 286749, 286751, 286755, 286759, 286775, 286782, 286797, 287142, 288592, 348910, 348914, 348935, 348974, 349005, 349014, 349020, 349021, 349023, 349026, 349027, 349028, 349033, 389564, 390925, 391541, 393971, 393982, 393993, 394864, 394865, 394867, 394868, 394869, 394870, 394881, 396035, 396065, 396418, 438244, 485965, 485974, 485975, 486202, 486403, 486404, 486408, 486417, 486618, 487336, 487345, 487348, 487397, 487398, 487403, 487404, 487416, 487422, 487424, 487428, 487667, 487670, 487674, 488032, 488058, 488082, 489336, 491403, 637814, 639816, 639817, 639821, 639825, 639831, 639850, 639872, 639994, 639997, 640009, 640010, 640014, 641518, 641572, 641674, 642371, 642385, 642558, 642568, 642569, 642628, 642631, 642661, 643065, 645224, 645967, 645968, 645969, 645970, 645971, 645979, 645986, 645988, 645989, 645990, 645995, 648740, 648745, 648747, 650370, 652820, 654649, 655742, 656093, 656180, 656568, 656591, 656595, 656612, 656883, 658231, 658431, 658600, 658742, 659167, 659930, 661502, 661605, 662730, 662758, 664710, 666322, 667076, 667442, 668238, 668828, 669307, 670334, 670846, 671335, 672216, 672280, 672695, 672944, 672957, 673163, 673530, 674428, 674430, 676088, 676319, 679659, 679969, 685618, 686649, 687797, 688022, 690091, 691656, 694854, 696067, 696769, 696774, 697453, 698680, 699163, 701519, 702332, 703151, 705296, 705630, 711909, 712097, 712915, 715610, 718096, 718751, 723826, 724252, 724277, 727203, 738786, 740359, 740480, 740807, 742297, 758747, 759437, 759561, 760651, 762703
brenda
-
atrium
brenda
-
CaMKII, no expression of CaMKIV
brenda
contains a heart type homotetrameric enzyme, H4
brenda
-
coronary artery smooth muscle
brenda
-
heart muscle
brenda
-
heart-type isozyme
brenda
high expression
brenda
high expression level
brenda
high expression level of GYS1
brenda
high expression of SMS1 mRNA
brenda
high SMS1 expression level
brenda
-
Keilin-Hartree muscle preparation
brenda
-
L-CPT I
brenda
-
left ventricular specimen
brenda
-
low activity
brenda
low expression
brenda
-
M-CPT I
brenda
-
MT1-MMP is increased in myocardial ischemia and reperfusion, myocardial, interstitial enzyme, microdialysis analysis, overview
brenda
-
muscle
brenda
-
newborn and adult
brenda
-
similar activity for ischemic tissue and normal tissue of hte same heart
brenda
very low expression level
brenda
-
weak activity
brenda
weak expression level of ADSS2 mRNA
brenda
-
brenda
glutamine synthetase protein is preferentially expressed in hepatocytes adjacent to oxygen-supplying capillaries and in previously CPS-positive hepatocytes. No shift towards a periportal or pericentral phenotype, overview
brenda
-
primary cultured hepatocyte
brenda
-
-
brenda
-
anterior
brenda
-
brenda
high expression of SMS1 mRNA
brenda
-
moderate activity
brenda
mRNA is abundant in the spleen, duodenum, jejunum, and ileum
brenda
-
-
35960, 36020, 80862, 137185, 288870, 288871, 391541, 653004, 653041, 655167, 664607, 665075, 665315
brenda
-
of piglet, crypt cells, glandular epithelium in the deeper submucosa has a very strong activity, villous epithelial cells show the most intense activity in the mucosa
brenda
-
35867, 35877, 36023, 94563, 208367, 396112, 438233, 438237, 439714, 439761, 487907, 642371, 643870, 643871, 643872, 643877, 655167, 655212, 665097, 667838, 667841, 739835, 757002
brenda
cDNA generated from, mRNA highly expressed
brenda
GC-C
brenda
-
intestinal mucosa
brenda
-
low activity
brenda
-
microvillus
brenda
-
mucosa
brenda
-
organ culture
brenda
-
proximal jejenum
brenda
-
small intestine
brenda
-
-
brenda
intestinal IPEC-J2 cell monolayer
brenda
-
brenda
-
72% of activity of renal cortex
brenda
-
brush-border membrane vesicles
brenda
-
evelopmental changes in morphometry of the jejunal enzyme activity during the first nine weeks of postnatal growth, overview
brenda
-
HMT activity comparable to activity in the colon
brenda
-
infection of porcine epidemic diarrhea virus to jejunum results in significant decreases leucine aminopeptidase N
brenda
mRNA is abundant in the spleen, duodenum, jejunum, and ileum
brenda
very low expression level
brenda
weak expression of SMS1 mRNA
brenda
A0A6M5K8J2, A0AAS4, A3KCL7, AF415202, B1PZW5, C1IHT9, D2XN65, F1RPC8, M1KCW7, P00336, P00339, P00371, P00636, P04574, P05024, P17560, P23687, P37111, P43367, P50578, P80041, Q29555, Q2TJA5, Q6RHW2, Q6RHW3, Q6RHW4, Q6Y0X5, Q8WN98, Q95284, Q9BDJ5, Q9BEC7, Q9MYU4, Q9TRC7
-
811, 1712, 2367, 2379, 2380, 2428, 2430, 2431, 2507, 2509, 2510, 2515, 2517, 2868, 2872, 2874, 2875, 2876, 2960, 3165, 3258, 3303, 4200, 4205, 4209, 4214, 4218, 4222, 4230, 4234, 4235, 4408, 4542, 4570, 5111, 5112, 5119, 5367, 6867, 6868, 6869, 6874, 6875, 26856, 28890, 28891, 28892, 33321, 33602, 33952, 34420, 35862, 35864, 35882, 35884, 35908, 35912, 35931, 35932, 35952, 35955, 36015, 36016, 36021, 36024, 36086, 36101, 36104, 36105, 36111, 36207, 36215, 36220, 36223, 36234, 36240, 36271, 36272, 36635, 36637, 36921, 36960, 81015, 81113, 81211, 81224, 81228, 81267, 81334, 81627, 81630, 81632, 81633, 81644, 95205, 95206, 95209, 95210, 95791, 95793, 95794, 95798, 95806, 135680, 135994, 136022, 136168, 136332, 136445, 136467, 136900, 136902, 136918, 137176, 137190, 137192, 170731, 170761, 170777, 170781, 170786, 171148, 171157, 171916, 171917, 171918, 171919, 171924, 171935, 172136, 172313, 207967, 208367, 208368, 208390, 209000, 209002, 209003, 209010, 209018, 209025, 209067, 209381, 209387, 209392, 209393, 209729, 209942, 210150, 210159, 246965, 246971, 285507, 285912, 285918, 285924, 285925, 286139, 286140, 286141, 286150, 286167, 286168, 286170, 286171, 286172, 286174, 286176, 286177, 286178, 286179, 286180, 286181, 286182, 286196, 286546, 286549, 286555, 286835, 286905, 287142, 287201, 287526, 287528, 288576, 288579, 288852, 288859, 288862, 288864, 288871, 288873, 347776, 347831, 347832, 348914, 348935, 389470, 389564, 389565, 390352, 390355, 390925, 391273, 391301, 391311, 391312, 391313, 391317, 391319, 391320, 391321, 391322, 391327, 391329, 391336, 391339, 391344, 391351, 391352, 391353, 391359, 391363, 391371, 391541, 391827, 391828, 391829, 391830, 391831, 391835, 391838, 391842, 391843, 391845, 391849, 391851, 391854, 391860, 391862, 391910, 391911, 391918, 391920, 391933, 391934, 393046, 393059, 393796, 394352, 394435, 394867, 396065, 396418, 438244, 440112, 440114, 440358, 441180, 441183, 485960, 485961, 485962, 485963, 485964, 485965, 485966, 485967, 485968, 485971, 485973, 485974, 485976, 487404, 487416, 487546, 487547, 487548, 487927, 487928, 487929, 488013, 488014, 488024, 488288, 488742, 489479, 491403, 636962, 638017, 638028, 639993, 639997, 640679, 641674, 641693, 642628, 642661, 643065, 643870, 643872, 643875, 643983, 643984, 645224, 645255, 645979, 646545, 646551, 646552, 646729, 647088, 647089, 647092, 647093, 647094, 647097, 647106, 648215, 648745, 648747, 649050, 649263, 649274, 649275, 649282, 649285, 649309, 650056, 650309, 650375, 650448, 650453, 650466, 650471, 651057, 651877, 651931, 652293, 652745, 653847, 653873, 654215, 654353, 654845, 655117, 655198, 655204, 655926, 657211, 658224, 658585, 659130, 660683, 661605, 661881, 662758, 663901, 664710, 664847, 665071, 665075, 665090, 665112, 667454, 667997, 668392, 668729, 668775, 668828, 668961, 669028, 669787, 670454, 672202, 672703, 674365, 674987, 675286, 677083, 677547, 677866, 678500, 678587, 678733, 679788, 680201, 680278, 680376, 680536, 682253, 683242, 683291, 683344, 683724, 683964, 684417, 685253, 686020, 686234, 686277, 686654, 687440, 687746, 688485, 688496, 688954, 692244, 693386, 695560, 695864, 695929, 696080, 696158, 696626, 696720, 696725, 696739, 696755, 696756, 697027, 697453, 698356, 698650, 698667, 699163, 699484, 699830, 699847, 700584, 700612, 701427, 701855, 702384, 702645, 705296, 705297, 705630, 706903, 707103, 707126, 707722, 707733, 707734, 707744, 708385, 709193, 709476, 710213, 710718, 711004, 711011, 711013, 711296, 711321, 711325, 711719, 711903, 712993, 712996, 713191, 714428, 714717, 715128, 715296, 717340, 717599, 717969, 718096, 718751, 719017, 720335, 720756, 721223, 723870, 724410, 726467, 729300, 732523, 732980, 734774, 735190, 737108, 740001, 741580, 742439, 743191, 743355, 743827, 743863, 744252, 745343, 745357, 746908, 750110, 750308, 751111, 752437, 752833, 757002, 760213, 762703, 762830, 763372, 763411, 763469, 765044, 765166
brenda
-
3 forms
brenda
-
ATPDase detected by immunoblotting in luminal side of the ductular epithelium
brenda
-
ATPDase/cd39 detected by immunoblotting in vascular endothelium and smooth muscles (blood vessel walls)
brenda
-
brush border membrane
brenda
-
brush-border membrane
brenda
-
brush-border membrane of cortex
brenda
-
brush-border region of the proximal tubules
brenda
cortex
2368, 2371, 2372, 2375, 2427, 2429, 2508, 2511, 2512, 35952, 35955, 36055, 36060, 81261, 81264, 81625, 81631, 81635, 286165, 286173, 391919, 393044, 636721, 642145, 642628, 647107, 647109, 647110, 649664, 653593
brenda
-
cortex, detected by immunoblotting in blood vessel walls of glomerular and peritubular capillaries
brenda
-
cortex, low activity
brenda
-
enzyme isolated from
brenda
-
epithelial cells
brenda
from newborn and 1-, 7-, 21-, 35-, 56-, and 210-day-old domestic pigs. The predominant organ for carnitine synthesis is likely the kidney at birth. The liver appears to predominate after the pig exceeds 7 days of age
brenda
GYS1
brenda
-
high activity
brenda
-
high enzyme activity
brenda
high enzyme expression level
brenda
high expression
brenda
high expression level
brenda
high expression level of ADSS2 mRNA
brenda
high expression of SMS1 mRNA
brenda
-
high level, in distal and proximal tubular structures
brenda
-
high sodium chloride intake decreases betaine-homocysteine S-methyltransferase expression
brenda
-
higher activity in cortex than in medulla. In inner medulla, the enzyme is mainly localized in cells surrounding the tubules
brenda
-
highest activity
brenda
-
highest total and specific activity
brenda
-
hog
brenda
intermediate abundance of the protein
brenda
-
isozyme ERAP1
brenda
-
L-CPT I
brenda
-
localized in cortex and medulla cells
brenda
low activity
brenda
low expression
brenda
low level of transcripts is detected in kidney
brenda
-
macula densa cells, isoform I
brenda
-
medulla
brenda
-
medulla, cortex
brenda
-
microvillar membrane
brenda
-
one enzyme form of 180000 Da
brenda
-
only in proximal tubular epithelial cells
brenda
-
outer medulla
brenda
-
presence of 2 isoforms
brenda
-
proximal tubes of cortex
brenda
proximal tubular cells
brenda
-
proximal tubule
brenda
-
proximal tubules
brenda
-
proximal tubuli
brenda
-
renal brush border
brenda
-
renal cortex
brenda
-
renal epithelial cell culture
brenda
-
renal mRNA expression and protein of neprilysin is substantially downregulated during rapid atrial pacing. Irbesartan therapy does not prevent down-regulation of neprilysin. In contrast, TGF-beta1 mRNA expression is up-regulated. Collagen and angiotensin II type 1 receptor expression are not significantly altered by rapid atrial pacing. Application of aldosterone, atrial natriuretic peptide, asymmetric dimethylarginine, and angiotensin peptides fail to cause down-regulation of renal neprilysin expression in vitro
brenda
-
richest source
brenda
-
significantly higher expression in liver than in kidney
brenda
-
transcripts are expressed at significant levels in the liver and kidney from day 45 of gestation onward
brenda
-
two forms: long chain oxidase, short chain oxidase
brenda
-
weak activity
brenda
-
-
brenda
high expression level of ADSS2 mRNA
brenda
medium expression level
brenda
-
of adults
brenda
-
-
brenda
-
weak activity
brenda
-
395399, 395400, 395403, 395406, 395408, 395409, 395410, 395425, 395428, 395429, 395431, 439442, 439443, 439452, 439456, 439479, 487383, 660111, 663821, 685330, 701926, 743324
brenda
-
polymorphonuclear
brenda
-
brenda
all cells with positive StS expression,exception: 65.1% StS expression in 50-day-old animal's Leydig cells
brenda
-
of neonatal pig. High expression of 11beta-hydroxysteroid dehydrogenase type 2 mRNA, resulting in oxidation from cortisol to cortison, with no detection of the reduction reaction. Activity of type 2 enzyme is higher than the oxidation activity of the type 1 enzyme
brenda
A0A287BBZ0, A0AAS4, A8HG48, B1PZW5, C1IHT9, D2XN65, F1RWA8, F1S025, I3LRP8, P00336, P00339, P00636, P51781, P53603, P79282, P80147, P83686, Q28943, Q28960, Q29555, Q3S3F7, Q5DT24, Q6RHW2, Q6RHW3, Q6RHW4, Q6Y0X5, Q8MIR4, Q95332, Q9BDJ5, Q9GJX5, Q9MYU4, Q9MZS9, Q9N119, Q9N1F5, Q9TUI8
-
517, 590, 1059, 1060, 1061, 1062, 1063, 1076, 1505, 1712, 2868, 2870, 2933, 2935, 2936, 2999, 3010, 3014, 3246, 3589, 3590, 3600, 3607, 3608, 3609, 3614, 3615, 3962, 4256, 4377, 4408, 5102, 5111, 5112, 5119, 5181, 5367, 5866, 6032, 6033, 6037, 6038, 6040, 33639, 33758, 33951, 33952, 34312, 34313, 34314, 34315, 34316, 34317, 34318, 34319, 34320, 34322, 34323, 34325, 34443, 35908, 35984, 35985, 36226, 36234, 36401, 36639, 36640, 36921, 36958, 80763, 81015, 81113, 94563, 94610, 94891, 95252, 95271, 95272, 134280, 134945, 135193, 135195, 135242, 135406, 135533, 136445, 137176, 170636, 170777, 170789, 170802, 170808, 170810, 170964, 170971, 170997, 171000, 171010, 171011, 171148, 171176, 171182, 171187, 171557, 171699, 171916, 171917, 171918, 171919, 171922, 171924, 171926, 171935, 171965, 172093, 172136, 172155, 172166, 207965, 207967, 208367, 208368, 208390, 208656, 208687, 209057, 209253, 209266, 209291, 209381, 209387, 209393, 209648, 209721, 209722, 209725, 209726, 209727, 209729, 209731, 209736, 210150, 210217, 285315, 285705, 285713, 285720, 285767, 285769, 285770, 285806, 286118, 286126, 286128, 286150, 286165, 286166, 286167, 286168, 286170, 286172, 286173, 286174, 286176, 286177, 286178, 286180, 286181, 286182, 286185, 286189, 286546, 286549, 286553, 286554, 286555, 286556, 286590, 286850, 286859, 287142, 287198, 287201, 287526, 287528, 287934, 287966, 288545, 288550, 288573, 288575, 288582, 288591, 288603, 288679, 289261, 289270, 347756, 348485, 348486, 348487, 348488, 348490, 348491, 348492, 348494, 348497, 348498, 348500, 348505, 348507, 348528, 348703, 348704, 349218, 349219, 349220, 349227, 349232, 349233, 349235, 389392, 389564, 389695, 389696, 389969, 389970, 389971, 390388, 390399, 390412, 390595, 390596, 390925, 391287, 391318, 391331, 391335, 391342, 391346, 391349, 391350, 391354, 391355, 391356, 391357, 391358, 391362, 391408, 391541, 391626, 392149, 392150, 392151, 392152, 392153, 392155, 392208, 392224, 392269, 392317, 392319, 392321, 392335, 392337, 392338, 392339, 392343, 392363, 392481, 392482, 392483, 392486, 392487, 392498, 392739, 392826, 393314, 393876, 394032, 394143, 394156, 394157, 394158, 394159, 394186, 394197, 394204, 394212, 394232, 394352, 394434, 394435, 394436, 394442, 394557, 394559, 394570, 394650, 394867, 394868, 395367, 395374, 395377, 395379, 395388, 395392, 395451, 395930, 396035, 396065, 396199, 396408, 396409, 396418, 437659, 437711, 437712, 438217, 438244, 440133, 441173, 441183, 441243, 441252, 441507, 441512, 441513, 441518, 441530, 441554, 441557, 441610, 485199, 485200, 485201, 485395, 485404, 485716, 485766, 485768, 485769, 485771, 485928, 485964, 485967, 485968, 485973, 485974, 485978, 486002, 486003, 486026, 486290, 486292, 486403, 486417, 486618, 486676, 486677, 486682, 486696, 486703, 486907, 487067, 487070, 487194, 487983, 488120, 488122, 488283, 488364, 488370, 488502, 488506, 488512, 488513, 488514, 488705, 488708, 488714, 488726, 489333, 489336, 489339, 489430, 489836, 489837, 489847, 636889, 637038, 637039, 637047, 637754, 637755, 637912, 637955, 638015, 638017, 638018, 638019, 638021, 638024, 638025, 638738, 638741, 639107, 639114, 639116, 639129, 639319, 639412, 639516, 639731, 639996, 640009, 640220, 640487, 641173, 641432, 641433, 641436, 641441, 641670, 641674, 641693, 641791, 642371, 642538, 642781, 642782, 642783, 642784, 642785, 642865, 643065, 643069, 643174, 643175, 643177, 643178, 643189, 644293, 644337, 644428, 644883, 645174, 645177, 645178, 645221, 645224, 645255, 645280, 645383, 645712, 646583, 646589, 646733, 647047, 647143, 648742, 648744, 648745, 648747, 649263, 650557, 650852, 650855, 650948, 651130, 651877, 652241, 652612, 653037, 653856, 654128, 654421, 654446, 654897, 654927, 655212, 657395, 657837, 658520, 658584, 658588, 658928, 659129, 659166, 659255, 659828, 660483, 660699, 661099, 662055, 662255, 662758, 663910, 664136, 664561, 664588, 664710, 665112, 667093, 667841, 668111, 668392, 668593, 668729, 668828, 669061, 669998, 671173, 671335, 671609, 672707, 673313, 674366, 675569, 679535, 680555, 683344, 683430, 684079, 685601, 686040, 687453, 688239, 688316, 688418, 692927, 695586, 696158, 697027, 697453, 699163, 699830, 699847, 701342, 701423, 702427, 702968, 703320, 704352, 704363, 704524, 705195, 705196, 705198, 705296, 705297, 705630, 706862, 706903, 707103, 707282, 707348, 711309, 712322, 712902, 712993, 712996, 718096, 718751, 721422, 724410, 724831, 725721, 726099, 727109, 727324, 727623, 729570, 729652, 735203, 736044, 740001, 740480, 740655, 742559, 743564, 744381, 746557, 746989, 747810, 750043, 750110, 750445, 751162, 757002, 757074, 760548, 760550, 760636, 761345, 761411, 761412, 761704, 761820, 762103, 762703, 762875, 765327
brenda
-
17betaHSD gene expression in liver, but not in testis, varies negatively with fat androstenone concentration. Immunocastrated and surgically castrated male pigs show significant increase of 3betaHSD expression. Fat androstenone is negatively correlated with liver 17betaHSD gene expression. The mRNA expression is generally much greater from the 3betaHSD than from the 17betaHSD gene
brenda
-
activity of gamma-butyrobetaine dioxygenase in the liver is lower in pigs treated with clofibrate than in control pigs. Concentrations of gamma-butyrobetaine does not differ between both groups
brenda
-
ATPDase detected by immunoblotting in bile canaliculi of hepatocytes
brenda
-
ATPDase/cd39 detected by immunoblotting in vascular endothelium and smooth muscles (blood vessel walls)
brenda
-
CPT I
brenda
dynamic expression pattern of the enzyme in hepatocytes of different zones of the liver lobule, overview
brenda
-
enzyme is expressed in a development-dependent fashion, expression appears restricted to the early fetal stages
brenda
-
expression of hepatic but not testicular 3beta-hydroxysteroid dehydrogenase shows a negative relationship with the level of backfat androsterone and is accompanied by a reduced rate of the hepatic androsterone clearance. Low expression of enzyme protein in the liver of high androsterone pigs is accompanied by a reduced level of enzyme mRNA
brenda
-
FMO activity is substantial in the liver microsomes of one-day-old neonatal pigs. This activity increases rapidly in 2 weeks of growth and then remains high. The highest porcine hepatic FMO activity is detected at the age of 20 weeks. Since both liver and body weight increase during the growth of pigs, the growth impact on the hepatic FMO activity is also assessed using in vivo intrinsic clearance of benzydamine N-oxidation at different ages. Although the highest in vivo intrinsic clearance is still at around 2-5 weeks age, the clearance is reduced at age of 20 weeks obviously
brenda
from newborn and 1-, 7-, 21-, 35-, 56-, and 210-day-old domestic pigs. The predominant organ for carnitine synthesis is likely the kidney at birth. The liver appears to predominate after the pig exceeds 7 days of age
brenda
GYS1
brenda
-
high activity
brenda
high expression
brenda
high expression level
brenda
high expression level of ADSS2 mRNA
brenda
high expression level of GYS2
brenda
high expression level of the lung-type and the liver-type isozymes
brenda
-
high level
brenda
-
high sodium chloride intake decreases betaine-homocysteine S-methyltransferase expression
brenda
-
highest activity
brenda
-
isozyme FMO1
brenda
-
L-CPT I
brenda
low activity
brenda
-
lymphomic
brenda
-
M-CPT I
brenda
-
male pigs with high androstenone concentrations in fat have low 3betaHSD gene expression in liver and testis. Immunocastrated and surgically castrated male pigs shows significant increase of 3betaHSD expression. Fat androstenone is negatively correlated with liver 3betaHSD gene expression. The mRNA expression is generally much greater from the 3betaHSD than from the 17betaHSD gene
brenda
moderate expression of SMS1 mRNA. DEcrease in mRNA expression and protein expression following turpentine treatment
brenda
-
multiple isoforms
brenda
-
of 2-week-old piglets. Activities in livers of fetal or suckling mammals and decreases at weaning so that the activity in adults is between 10 and 20% of the maximum attained during development
brenda
-
of adults
brenda
-
only slight activity
brenda
-
presence of 2 isoforms
brenda
regulatory subunit MAT2beta is expressed at a higher level in liver and duodenum, followed by the stomach, fat and longissinus dorsi muscle
brenda
-
significantly higher expression in liver than in kidney
brenda
SULT2A1
brenda
-
transcripts are expressed at significant levels in the liver and kidney from day 45 of gestation onward
brenda
-
UGT activities in the microminipig are similar to those in the minipig
brenda
-
very abundant
brenda
-
weak activity
brenda
-
34550, 672202, 674599, 699484, 714523, 721706, 724130, 745343, 745357, 749861, 759691, 763868
brenda
-
a proximal tubule cell line
brenda
-
a renal epithelial cell line
brenda
-
CRL 1392 (ATCC)
brenda
-
in the membrane of porcine LLC-PK1 cells stably expressing rabbit gastric H+,K+-ATPase, [(dihydroindenyl)oxy]acetic acid inhibits activities of endogenous Na+,K+-ATPase
brenda
-
LLC-PK1 cells stably expressing alpha- and beta subunits of the gatric H+,K+-ATPase
brenda
and cerebellum, similar expression pattern that is at a low level at birth and increasing with aging to the highest level at postnatal day 8 in longissinus dorsi muscle and postnatal day 14 in cerebrum. Weaning decreases the expression level of the GPD1 gene
brenda
regulatory subunit MAT2beta is expressed at a higher level in liver and duodenum, followed by the stomach, fat and longissinus dorsi muscle. MAT2beta mRNA abundance is lower in both subcutaneous adipose tissue and skeletal muscle in obese pigs compared with lean pigs. MAT II beta protein content is lower in skeletal muscle in obese than in lean pigs
brenda
-
the samples for gene expression analyses are taken 0.5 h after slaughter
brenda
A0AAS4, A9CQL8, B1PZW5, P00336, P00339, Q2TJA5, Q6RHW2, Q6RHW3, Q6RHW4, Q6Y0X5, Q9MYU4
-
1712, 3165, 3166, 3173, 3200, 81209, 81211, 81260, 81262, 81282, 81364, 81631, 81644, 134875, 135449, 208367, 208390, 210150, 210159, 285912, 285918, 286182, 347757, 390827, 390828, 396418, 438244, 485965, 489334, 489336, 491403, 639329, 641674, 643065, 645224, 645255, 652617, 659129, 661605, 662758, 664710, 668729, 668828, 669015, 669028, 671335, 680284, 683344, 687797, 691656, 697453, 699163, 701641, 707126, 710213, 712996, 718096, 718751, 721982, 740001, 762703
brenda
-
bronchial epithelium
brenda
-
ciliated cells, nonciliated bronchiolar cells, Type II alveolar pneumocytes, epithelial cells of the ducts of the bronchial gland
brenda
GYS1
brenda
-
high activity
brenda
high expression
brenda
-
high expression of isozyme FMO2
brenda
high expression of SMS1 mRNA
brenda
intermediate abundance of the protein
brenda
-
located on endothelial cells in blood vessels
brenda
-
low activity
brenda
medium expression level
brenda
-
moderate activity
brenda
-
pulmonary arteries, veins, airway epithelium, and nerves, developmental regulation of GTP-CH1, equally expressed in pulmonary hypertensive and healthy piglets
brenda
-
trachea submucosal gland
brenda
-
-
brenda
H3-K4 mono-, di-, and tri-methylation in large luteal cells increases as differentiation evolves but remains low in small luteal cells
brenda
-
brenda
mandibular lymph node
brenda
-
moderate activity
brenda
-
normal and leukemic
brenda
-
-
brenda
-
from mesenteric lymph nodes
brenda
-
from thymus, spleen, lymph node and peripheral blood. Highest activity in peripheral blood lymphocytes
brenda
-
mesenteric lymph node
brenda
-
mesenteric lymph nodes
brenda
-
peripheral, very low activity
brenda
-
-
brenda
alveolar mactrophage
brenda
-
HAS1 expression is shown in 55.7% of SIRPA-positive macrophages in stage III follicles
brenda
-
peritoneal, alveolar
brenda
-
-
brenda
-
alpha-lactalbumin, a mammary-specific protein
brenda
-
brenda
weak expression of SMS1 mRNA
brenda
-
-
brenda
-
antrum mucosa
brenda
-
fundic mucosa
brenda
-
vaginal mucosa
brenda
-
2624, 2842, 3246, 3258, 4408, 4932, 33532, 33638, 35867, 81336, 81345, 94445, 94894, 171390, 246781, 286168, 286177, 287914, 287967, 485964, 485965, 485967, 485968, 485971, 485973, 485974, 485975, 487336, 637814, 637955, 642251, 642265, 642289, 642298, 642301, 642558, 642570, 642571, 648740, 648745, 653873, 658034, 661121, 661690, 662758, 670846, 679947, 683344, 693573, 704363, 708215, 709797, 712993, 714523, 729863, 730996, 762703
brenda
-
4 different enzymic activities of D-glucose 1,6-bisphosphate synthesis: in muscle glucose 1-phosphate transphosphorylase activity is the major activity, but not in brain
brenda
-
a reduced protein diet increases SCD protein expression and activity
brenda
-
a reduced protein diet significantly increases protein expression and activity
brenda
ADSS1 is predominantly expressed in the striated muscle tissue, ADSS1 is up-regulated significantly along with muscle growth
brenda
-
Biceps femoris, enzyme activity during processing of Jinhua ham
brenda
-
coronary artery smooth muscle
brenda
-
enzyme is more active in longissimus dorsi than in masseter. In both muscles the activity begins to fall at temperatures below 39°C and is almost zero when the temperature decreases to below 15°C. The activity of GDE may control the rate of glycogenolysis and glycolysis, but does not block rapid glycolysis and pH decrease when the temperature is high
brenda
-
increase in expression with growth stage, higher expression in muscle than in adipose tissue
brenda
-
left ventricular heart muscle
brenda
longissimus dorsi muscle, lipin1 gene and its isoforms
brenda
-
low activity
brenda
-
masseter and longissimus dorsi
brenda
-
only isoform PMCA1
brenda
-
skeletal
brenda
-
skeletal muscle
brenda
-
smooth muscle cell
brenda
-
-
brenda
-
ischemic and nonischemic remote myocardium
brenda
-
isozyme CaMKIIdelta splicing variants deltaB and deltaC
brenda
-
the MAPK family enzymes have regulatory function in the myocardium
brenda
-
brenda
-
HSDB1 transcript abundance in the endometrium and myometrium remain at the same level during the examined days of pregnancy. After luteolysis both endometrial and myometrial HSD3B1 expression wane
brenda
intermediate abundance of the protein
brenda
-
PGH2 9-,11-endoperoxide reductase activity is expressed and active at early pregnant sows, probably also in cyclic sows
brenda
-
three isoforms of nitric oxide synthase are mainly localized in the uterine luminal and glandular epithelium and myometrium, and the intensity of immunostaining for inducible nitric oxide synthase and endothelial nitric oxide synthase increases gradually with temporal development of the postnatal uterus. The total nitric oxide synthase and inducible nitric oxide synthase activities are significantly increased at postnatal days 21 and 35. Although constitutive nitric oxide synthase activity is increased at postnatal day 21, it decreases subsequently at postnatal day 35. Inducible nitric oxide synthase protein expression is significantly increased at postnatal days 21 and 35
brenda
-
-
brenda
-
parallel to the circular and to the longitudinal muscle
brenda
-
-
brenda
-
CaMKIV
brenda
-
myelinated and unmyelinated neurons of the peripheral nervous system
brenda
-
peripheral nitrergic nerves, isoform I
brenda
primary cultured cells
brenda
-
brenda
-
cultured cells
brenda
MII oocyte
brenda
-
overall level of UCH-L1 increases during maturation
brenda
-
UCHL1 present in the cortex, UCHL3 is primarly associated with the meiotic spindle of metaphase II ova
brenda
-
brenda
-
during meiotic resumption of oocytes
brenda
-
-
brenda
-
expression of isoform HAS1 in theca cells of healthy and early atretic follicles of stage I and stage II and in progressing atretic stage III follicles
brenda
-
1712, 95233, 136445, 287201, 287528, 637814, 647180, 662758, 671335, 679288, 702525, 705630, 713952, 718096, 718751, 721422, 739860
brenda
cellular and follicular stage-specific patterns of histone H3 methylation at lysine 4 in porcine preovulatory follicles and during luteinization in pig ovaries, overview. LSD1/KDM1 expression is restricted to the corpus luteum. While granulosa cells of primary, secondary, and early antral follicles are negative for H3-K4 methylation those from large antral follicles show a striking upregulation in the cells located in the proximity to the oocyte
brenda
-
enzyme activity of prepuberal gilts rises with the onset of estrus, again just prior to ovulation on day 21, and during pregnancy. The activity is markedly elevated during the luteal and proestrous phases compared to the postovulatory phase. The highest specific activities occur at the proestrus when the follicle wall is undergoing breakdown
brenda
GYS1
brenda
low expression level
brenda
within ovary, expression is confined to oocytes, remains stable during oocyte maturation
brenda
-
1712, 29637, 35862, 36228, 36232, 36335, 36338, 36368, 36380, 36382, 36390, 36510, 36560, 36565, 36566, 36567, 36574, 36575, 36578, 80811, 80812, 80813, 80814, 80815, 80816, 80817, 80818, 80819, 80820, 80821, 80822, 80823, 80824, 80836, 80852, 80853, 81631, 95318, 95320, 95321, 95367, 133823, 133843, 133844, 133845, 133846, 133852, 133857, 133860, 133874, 133892, 133893, 133899, 133900, 133901, 133902, 133903, 133904, 133905, 133911, 133922, 133923, 133924, 133925, 133926, 133927, 133928, 133929, 133930, 133931, 133936, 134211, 134523, 134528, 171875, 171965, 210138, 210142, 210144, 210150, 393315, 393418, 393424, 396418, 485964, 485965, 485966, 485967, 485968, 485971, 485973, 485974, 485976, 485978, 488824, 640014, 641674, 645224, 647481, 647484, 647485, 647492, 647499, 647508, 649122, 649193, 649222, 649362, 649429, 649693, 650242, 650354, 650378, 650478, 650546, 650565, 650817, 652623, 656528, 658338, 663908, 664095, 664154, 664171, 664172, 664793, 665418, 665673, 666544, 666839, 667154, 667691, 668111, 668815, 669505, 678567, 679917, 680742, 681300, 681436, 682444, 682500, 682721, 691224, 691647, 691654, 691901, 692595, 692652, 693794, 693798, 694610, 694611, 694982, 695047, 695698, 697445, 699727, 699820, 700339, 701270, 701345, 702374, 704143, 704524, 705297, 706903, 706963, 707280, 707576, 707593, 707619, 707714, 707828, 708047, 708485, 708869, 709268, 709785, 709949, 710556, 710597, 711489, 714754, 715996, 717246, 729305, 729330, 729673, 729737, 729771, 730743, 731812, 731969, 732930, 749560, 749562, 750808, 751257, 751273, 751440, 751531, 752394, 752395, 752608, 753339, 753855, 754151, 754203, 754277, 755101
brenda
-
2 commercially available enzymes
brenda
-
activity is first detected at 6-7 days of age, glucocorticoids stimulate the perinatal development of pancreatic enzymes
brenda
commercial preparation
brenda
-
high sodium chloride intake has no effect on betaine-homocysteine S-methyltransferase expression
brenda
-
islet cells, isoform I
brenda
-
moderate activity
brenda
-
the piglet pancreatic GAMT activity is only 1% of that found in the liver
brenda
-
very high activity
brenda
very low expression level
brenda
-
brenda
low activity
brenda
-
-
brenda
-
brain
brenda
-
brenda
-
growth hormone-positive cells and almost all proopiomelanocortin-positive cells
brenda
-
only isoform SPCA1
brenda
-
-
brenda
-
expression of ketohexokinase mRNA increases from day 30 to 40 of pregnancy
brenda
-
PGDH protein is concentrated in the parietal yolk sac membrane (PYS) lining the placental surface and in placental blood vessels
brenda
-
variant HPSE v1 and v2 mRNA are localised to the cuboidal trophoblast cells of the folded bilayer located nearest to the maternal endometrium. The enzyme likely plays a role in the development and modification of the pig placenta
brenda
-
-
brenda
-
expression is observed in the membranes of vacuoles contained in prostate secretions as well as in the endothelium of arterioles and venules
brenda
-
presence of 11beta-hydroxysteroid dehydrogenase mRNA transcripts and protein in all tissues of the reproductive tract examined, but cortison-cortisol interconversion is undetectable in the corpus and cauda epididymides, vas deferens, vesicular and prostate glands
brenda
-
-
brenda
-
basolateral membranes from the outer cortex
brenda
-
basolateral membranes of kidney proximal tubule cells
brenda
MIOX is a tubular-specific enzyme
brenda
-
-
brenda
-
bipolar cells of the retina
brenda
-
calpain-5 is found in the inner segment of photoreceptor cells
brenda
-
brenda
GYS1
brenda
-
-
brenda
-
present in many, but not all Schwann cell membranes
brenda
-
-
36460, 36465, 36467, 36469, 36472, 36476, 36477, 36485, 135690, 690120, 755574
brenda
mainly localized to the principal piece of the porcine sperm flagellum
brenda
-
-
brenda
-
almost undetectable
brenda
-
GPx is detected in the tubulo-alveolar structures of the gland's parenchyma, in the apical part of secreting epithelial cells of the gland's alveoli, and in the vascular endothelium of blood vessels found in interstitial connective tissue
brenda
-
-
35908, 95300, 209067, 393322, 393513, 437997, 437998, 438003, 438006, 438010, 438015, 438025, 646500, 647277, 647282, 647286, 675286, 742066
brenda
-
enzyme degradation kinetics
brenda
-
mammalia
brenda
-
31325, 31338, 36003, 36010, 36195, 134945, 210150, 210159, 286245, 395498, 639993, 640009, 640014, 640632, 642258, 643972, 645167, 649014, 649015, 655198, 660701, 667816, 669060, 669062, 671335, 675569, 679288, 680538, 683344, 699163, 705297, 708827, 709776, 709799, 709800, 712996, 713952, 717628, 718096, 761337
brenda
AMPD1 is expressed specifically in skeletal muscle
brenda
-
calpain 3 may be involved in the mechanism of exogenous growth hormone action on skeletal muscle growth. Recombinant porcine growth hormone up-regulates mRNA expression of calpain 3 in a muscle type-specific manner, being more remarkable in semitendinosus muscles than in longissimus dorsi
brenda
contains a skeletal muscle type homotetrameric enzyme, M4
brenda
-
CPT I
brenda
-
diaphragm
brenda
-
intermyofibrillar and subsarcolemmal
brenda
-
Jinhua ham, biceps
brenda
longissimus dorsal muscle
brenda
longissimus dorsi muscle, high expression level of GYS1
brenda
longissimus, low expression level
brenda
-
M-CPT I
brenda
-
muscle-specific enolase
brenda
-
muscle-type isozyme, i.e. M4 isoform
brenda
-
musculus longissimus dorsi and musculus semimembranosus
brenda
Pgam2 is expressed at a high level in skeletal muscle during all the development stages
brenda
weak expression level of ADSS2 mRNA
brenda
-
brenda
-
distribution of esterases in skin. Skin from ear and back of male minpig shows higher enzyme activity than female
brenda
-
epidermis
brenda
-
fetus
brenda
-
low activity
brenda
-
35908, 36092, 36097, 36098, 208757, 326255, 395410, 487907, 488753, 488754, 488755, 488776, 639329, 656897, 664607, 668312, 686040, 705297, 709194, 718751, 762703
brenda
-
brush-border membrane
brenda
-
cIGnT is the dominant form
brenda
-
developmental changes in morphometry of the small intestine enzyme activity during the first nine weeks of postnatal growth, overview
brenda
high expression level of ADSS2 mRNA
brenda
-
highest enzyme activity per tissue protein
brenda
-
ileum
brenda
intestinal enzyme abundance declines progressively during the 28-day suckling period
brenda
low activity
brenda
low expression level
brenda
-
mucosa
brenda
-
no significant temporal alterations in the activity in foetal and newborn small intestine. Birth is followed by a 2-8fold decrease in activity, depending on the region of the small intestine. Increase in activity from duodenum to ileum
brenda
-
-
brenda
-
aortic
brenda
-
-
brenda
-
acrosin is a major serine proteinase of mammalian sperm
brenda
-
AS-A is a membrane protein of boar capacitated sperm
brenda
-
changes in SOD activity in boar sperm during preservation at 16°C, overview
brenda
-
the presence of 0.5 mM glucose induces total hexokinase activity in supernatants from sperm extracts of 1.7 mIU/mg protein, while the same concentration of both fructose, mannose, and sorbitol induces total hexokinase activity from 0.3 mIU/mg protein to 0.60 IU/mg protein. Diluted boar sperm from fresh ejaculates phosphorylates glucose through the hexokinase step much more efficiently than fructose or mannose. This difference facilitates a much more rapid intake of glucose into glycolysis than the other sugars
brenda
-
UCHL3 is localized to the acrosomal surface. UCHL1 is absent from the sperm surface
brenda
-
-
brenda
-
UCHL3 mainly localized to the round spermatids (acrosomal cap) and elongating spermatids (caudal manchette and acrosome)
brenda
-
expression level of UCH-L1, high or low, is associated with spermatogonial stem cell self-renewal and differentiation, overview
brenda
-
UCHL1
brenda
-
-
brenda
epididymal caput, corpus, and cauda sperm, isozymes PDIA3 and PDI-P5. PDI-P5 is downregulated from the epididymal corpus to cauda sperm, while PDIA3 is constitutively expressed
brenda
-
expressed in the postacrosomal sheath region
brenda
-
GPX4
brenda
-
in postacrosomal sheath and connecting piece of spermatozoa
brenda
-
in the acrosome of the sperm head and in the fibrous sheath of the principal piece of the flagellum
brenda
initially present in the sperm acrosomal vesicle of mammalian spermatozoa as the zymogen form, proacrosin, converted to the active form during the acrosome reaction, after which most acrosin molecules are released from the acrosomal vesicle, with a portion remaining associated with the sperm
brenda
-
localized in the mid-piece and principal piece of the flagellum as well as in the acrosomal area at the top of the head and in the cytoplasmic droplets released from the mid-piece after ejaculation
brenda
-
PFK shows no tight binding to sperm structures. It can readily be extracted from ejaculated boar spermatozoa by sonication. PFK is localized in the mid-piece and principal piece of the flagellum as well as in the acrosomal area at the top of the head and in the cytoplasmic droplets released from the mid-piece after ejaculation
brenda
-
PK-S is found in the principal piece of the boar sperm flagellum and in the acrosomal region of the sperm head and at the head-midpiece junction
brenda
-
brenda
high expression of SMS1 mRNA
brenda
-
isoform I
brenda
low expression level
brenda
-
pial membranes associated with brain and spinal cord
brenda
A0AAS4, A8WAC5, B1PZW5, P00336, P00339, Q6RHW2, Q6RHW3, Q6RHW4, Q6Y0X5, Q9MYU4, Q9N1F5
-
1712, 2797, 36193, 36624, 36637, 36916, 36921, 36924, 36928, 36940, 36946, 134136, 134137, 134142, 134145, 134146, 134149, 134155, 134283, 134289, 134304, 134307, 134315, 171699, 171965, 210150, 285912, 288579, 394570, 396418, 437788, 438244, 438251, 439714, 441557, 485965, 485968, 486646, 486653, 637955, 638826, 639329, 641674, 641693, 641695, 643065, 645224, 645255, 651877, 656707, 659129, 662758, 664710, 668729, 668828, 671335, 677864, 679288, 679414, 697453, 697900, 699163, 711142, 718096, 718751, 740001, 742811, 762703
brenda
GYS1
brenda
-
high activity
brenda
high expression
brenda
-
low activity
brenda
low expression level
brenda
moderate expression of SMS1 mRNA
brenda
mRNA is abundant in the spleen, duodenum, jejunum, and ileum
brenda
-
multiple isoforms
brenda
very low expression level
brenda
-
36859, 36888, 210150, 246848, 246854, 246865, 246866, 246868, 395410, 396418, 437659, 488370, 638139, 638322, 640014, 668809, 669014, 671335, 672636, 685586, 700593, 705297, 711245, 711398, 712877, 712894, 713952, 718751, 732680, 734202, 735163, 740001, 750685, 751358, 751533, 752229, 752233, 753869, 755084, 755552, 762703, 763226
brenda
-
gastric membrane
brenda
-
gastric mucosa
brenda
GYS1
brenda
high expression level of ADSS2 mRNA
brenda
-
low activity
brenda
low expression level
brenda
low SMS1 expression level
brenda
-
moderate activity
brenda
-
mucosa
brenda
-
poor source
brenda
regulatory subunit MAT2beta is expressed at a higher level in liver and duodenum, followed by the stomach, fat and longissinus dorsi muscle
brenda
weak expression of SMS1 mRNA
brenda
-
489165, 489169, 489171, 489178, 489201, 489342, 489343, 489356, 489367, 636794, 636795, 636796, 636797, 636798, 636800, 636803, 637812, 637813, 637814, 639316, 645223, 645255, 645280
brenda
-
high enzyme concentration
brenda
-
not
brenda
A5D9J3 AND A5D9J7
-
brenda
-
CaMKIV
brenda
-
DGK-Ialpha
brenda
-
1712, 81644, 136445, 208530, 246772, 246800, 285986, 285987, 285988, 286182, 287077, 287084, 287097, 287098, 287103, 287106, 287201, 287227, 287229, 287230, 287231, 287528, 288555, 389393, 389394, 390119, 390134, 390143, 396194, 396197, 396222, 485965, 646385, 662758, 663277, 668828, 669061, 671335, 683344, 686040, 695080, 697453, 699847, 702727, 708623, 709194, 710669, 711719, 718096, 718751, 721422, 760487, 761704, 762367
brenda
-
acrosin is expressed in the testis, where it is stored in the acrosomal cap of sperm in its inactive form, proacrosin
brenda
-
CaMKIV
brenda
-
expression of hepatic but not testicular 3beta-hydroxysteroid dehydrogenase shows a negative relationship with the level of backfat androsterone
brenda
-
GPX4
brenda
-
greater lyase than hydroxylase activity
brenda
high expression in adult male testis
brenda
high expression in adult male testis, low expression in young male testis
brenda
-
high expression of the gene CDS1 in testis
brenda
-
high expression, proteolytic processing occurs mainly in the testis
brenda
-
Immunocastrated and surgically castrated male pigs shows significant increase of 17betaHSD expression. The mRNA expression is generally much greater from the 3betaHSD than from the 17betaHSD gene
brenda
-
increase in the prepubertal testis
brenda
isozyme expression analysis
brenda
-
L-CPT I, not M-CPT I
brenda
-
Leydig and Sertoli cells
brenda
-
male pigs with high androstenone concentrations in fat have low 3betaHSD gene expression in liver and testis. Immunocastrated and surgically castrated male pigs shows significant increase of 3betaHSD expression. The mRNA expression is generally much greater from the 3betaHSD than from the 17betaHSD gene
brenda
-
neonatal
brenda
-
of neonatal pig
brenda
prepubertal and postpubertal testes of pigs
brenda
-
pronounced 11beta-hydroxysteroid dehydrogenase activity in presence of NADP+ and NAD+
brenda
SETDB1 expression gradually increases during testis development
brenda
SULT2A1
brenda
-
UCH-L1 is exclusively expressed in spermatogonia among male germ cells. In the adult testis, UCH-L1, high or low, is expressed only in a single layer of spermatogonia at the basement membrane
brenda
-
UCHL1 and UCHL3
brenda
-
-
brenda
-
platelets
brenda
-
134886, 208528, 210150, 392224, 395410, 485362, 485404, 485965, 639329, 662758, 718751
brenda
-
capsule, subcapsular zone, Hassall's corpuscles
brenda
-
119, 121, 2869, 2872, 5728, 36921, 95063, 134557, 208720, 209618, 209683, 288609, 348499, 389512, 391726, 439714, 439716, 489522, 636491, 636492, 636493, 636494, 636495, 636496, 636497, 636498, 636499, 641672, 641673, 642867, 645087, 664710, 671592, 704417, 712628, 718751
brenda
-
isoform Duox2, strong expression
brenda
low expression
brenda
-
brenda
-
developing
brenda
-
NAD+-dependent 11beta-hydroxysteroid dehydrogenase activity
brenda
-
wide distribution of enzyme isoform PDE5, nerve-induced relaxation of urethral preparations are enhanced at low concentrations of enzyme inhibitors sildenafil, vardenafil, and tadalafil, with direct smooth muscle-relaxant actions of the inhibitors at high concentrations
brenda
-
brenda
endometrial 17beta-hydroxysteroid dehydrogenase activity is decreased on days 15-16 in pregnant and cyclic pigs compared with the preceding days
brenda
-
expression of ketohexokinase mRNA is greater from day 9 through 17 of pregnancy compared to the corresponding days of the estrous cycle. There is an increase in expression of KHK mRNA through day 85, with peaks at days 30 and 85. Ketohexokinase protein is only detectable in GE of the endometrium at day 30 of pregnancy
brenda
-
high expression of conceptus and endometrial terminal CBR1 after initiation of blastocyst attachment suggest its involvement in early placentation
brenda
-
HSDB1 transcript abundance in the endometrium and myometrium remain at the same level during the examined days of pregnancy. After luteolysis both endometrial and myometrial HSD3B1 expression wane
brenda
-
the kallikrein-kininogen-kinin system is biologically active during establishment of pregnancy in the pig
brenda
-
136445, 661605, 663765, 671335, 697628, 707640, 708237, 718751, 725807, 739860, 751639, 762367
brenda
-
cyclic changes dependent on the estrous cycle. Changes observed mostly in the luminal epithelium and some endometrial glands. Localization and correlation between NADPH-diaphorase and nitric oxide synthase isoforms
brenda
-
expression of KLK4 is more intense in the stroma and uterine epithelium from days 0 to 10 of the estrous cycle
brenda
GYS1
brenda
-
luminal and glandular epithelium
brenda
medium expression level
brenda
-
PGFS mRNA and protein expression in the endometrium does not differ between pregnancy and oestrous cycle but PGFS mRNA in the myometrium increases during pregnancy both in the gravid and the non-gravid uterine horns
brenda
-
three isoforms of nitric oxide synthase are mainly localized in the uterine luminal and glandular epithelium and myometrium, and the intensity of immunostaining for inducible nitric oxide synthase and endothelial nitric oxide synthase increases gradually with temporal development of the postnatal uterus. The total nitric oxide synthase and inducible nitric oxide synthase activities are significantly increased at postnatal days 21 and 35. Although constitutive nitric oxide synthase activity is increased at postnatal day 21, it decreases subsequently at postnatal day 35. Inducible nitric oxide synthase protein expression is significantly increased at postnatal days 21 and 35
brenda
-
-
brenda
-
presence of 11beta-hydroxysteroid dehydrogenase mRNA transcripts and protein in all tissues of the reproductive tract examined, but cortison-cortisol interconversion is undetectable in the corpus and cauda epididymides, vas deferens, vesicular and prostate glands
brenda
-
weak enzyme expression
brenda
-
-
brenda
-
both PKG-Ialpha and PKG-Ibeta
brenda
-
-
brenda
-
presence of 11beta-hydroxysteroid dehydrogenase mRNA transcripts and protein in all tissues of the reproductive tract examined, but cortison-cortisol interconversion is undetectable in the corpus and cauda epididymides, vas deferens, vesicular and prostate glands
brenda
additional information
-
-
brenda
additional information
-
3 isoforms: 1. neuronal, soluble isoform I is constitutively expressed in brain and other tissues and Ca2+-regulated, 2. soluble isoform II is usually not constitutively expressed, but inducible in macrophages and other cells, 3. isoform III is membrane-bound and expressed in endothelial cells
brenda
additional information
-
absent from submaxillary glands
brenda
additional information
ADSS1 is undetectable in lung, liver, spleen, stomach, fat, lymph, kidney, and intestine
brenda
additional information
-
almost all organs
brenda
additional information
-
analysis of ATGL gene and protein expression in vitro and in vivo, tissue expression analysis, overview
brenda
additional information
-
BCMO1 expression in the exocrine portion of the pancreas, epidermis of the skin, and ciliary body pigment epithelia and RPE of the eye
brenda
additional information
-
conceptus tissue, KLK4 expression is greatest on day 10 with expression declining after day 14 of gestation
brenda
additional information
-
development-related patterns of D-Asp expression differ among various mammalian tissues, overview
brenda
additional information
distribution in various tissues
brenda
additional information
endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25
brenda
additional information
-
enzyme activity is found in almost all tissues
brenda
additional information
-
enzyme can be associated with endoplasmic reticulum, nuclear envelope and plasma membrane even within the same cell
brenda
additional information
-
enzyme expression analysis
brenda
additional information
-
enzyme expression is induced by gonadotropin
brenda
additional information
enzyme expression is restricted to developimg teeth
brenda
additional information
-
enzyme quantity is stable during meiotic maturation
brenda
additional information
expression is found in 4-day-old and 6-week-old pig liver, but not in fetal liver
brenda
additional information
expression of ADSS2 gene is relatively constant in the prenatal period and remains constant at a relatively higher expression level in postnatal period
brenda
additional information
-
expression of isoform Duox2 in all tissues of the digestive tract examined. Enzyme is located at the apical membrane of the enterocytes in the brush border
brenda
additional information
-
factor Xa binds to cell surfaces
brenda
additional information
GSNOR protein is expressed at all stages during porcine preimplantation embryo development in both cytoplasmic and nuclear of preimplantation embryos, but gradually reduced during embryo development
brenda
additional information
-
high activities in tissues where turnover of energy from adenine nucleotides is great, e. g. muscle
brenda
additional information
immunohistochemic analysis
brenda
additional information
-
immunohistochemic analysis, overview
brenda
additional information
-
immunohistochemic localization analysis, overview
brenda
additional information
-
in crude pepsin preparation
brenda
additional information
-
in PCAEC cells, plasmin induces an endothelium-dependent relaxation and a concentration-dependent transient elevation in the cytosolic Ca2+ concentrations. Plasmin concentration-dependently induces NO production
brenda
additional information
-
in pigs, gonocytes and spermatogonia expressing UCH-L1 include the population expressing PLZF, a known determinant of undifferentiated spermatogonial stem cells, asymmetric segregation of UCH-L1 and PLZF in spermatogonia in vivo and in vitro, overview
brenda
additional information
in somatic cells, LDH forms homotetramers and heterotetramers that are encoded by two different genes: LDHA (skeletal muscle type, M) and LDHB (heart type, H)
brenda
additional information
-
in vitro physical interaction between LEI/L-DNase II and PARP-1. positive effect of LEI (and, to a lesser extent, of L-DNase II) on PARP-1 activity
brenda
additional information
isozyme expression levels and tissue distribution, overview
brenda
additional information
level and pattern of Hyal1 expression in different tissues
brenda
additional information
level and pattern of Hyal2 expression in different tissues
brenda
additional information
level and pattern of Hyal3 expression in different tissues
brenda
additional information
-
low activity or absent in rat liver, stomach and submaxillary glands and pig submaxillary glands
brenda
additional information
mechanism underlying metabolic zonation, overview
brenda
additional information
-
MMP-2 activity in tissues taken from newborn piglets undergoing hypoxia and reoxygenation, overview
brenda
additional information
-
no activity in intestine
brenda
additional information
-
no activity in pancreas, brain, aorta, heart
brenda
additional information
no activity in small intestine
brenda
additional information
no activity in spleen, heart, lung, stomach, large intestine, cerebrum, cerebellum, submaxillary gland, and thymus
brenda
additional information
-
no enzymatic activity in any tissue other than liver and kidney
brenda
additional information
-
no expressed in small intestine, stomach, kidney, ovary or testis
brenda
additional information
-
not in leukocytes and ascites tumor cells
brenda
additional information
-
not in submaxillary glands
brenda
additional information
-
not: skeletal muscle, heart muscle, brain spleen, adrenals, red cells, plasma, serum
brenda
additional information
-
ontogeny, enzyme activity, and tenzyme expression throughout growth and development, overview
brenda
additional information
-
overview
brenda
additional information
-
overview about distribution in animal tissues
brenda
additional information
-
overview tissue distribution of mitochondrial enzyme
brenda
additional information
-
overview: distribution in animal tissues
brenda
additional information
-
Plox-86 cells overexpress leukocyte-type 12/15-LO. Significant increase of monocyte chemoattractant protein-1 mRNA in Plox-86 cells
brenda
additional information
porcine GPD1 gene is expressed in almost all tissues but its levels of expression vary widely over 2 orders of magnitude
brenda
additional information
-
quantitative expression analysis
brenda
additional information
relationship between the expression of hepatic but not testicular enzyme with androstenone deposition in pig adipose tissue
brenda
additional information
SMS1 tissue expression analysis, overview
brenda
additional information
SULT2B1 expression is absent or low in the testis. Tissue samples were collected from a total number of ten postpubertal crossbreed boars (nine German Landrace × Pietrain, one Large White) aged between 10 and 16 months. When measuring P5-ST activities in cytosols, conversion rates of the substrate is only marginal in testis, epididymal head and the initial segment of the epididymal body. They increased in the subsequent segments of the epididymal body and are maximal in the epididymal tail. When measuring the sulfonation of pregnenolone (P5) in homogenates prepared from the testis and selected segments (EH1, ET1) of the epididymis, as in cytosols sulfonation activities are high in epididymal tail and only marginal in epididymal head
brenda
additional information
-
the mRNA expression of porcine JHDM1A is significantly higher in the middle at 65 days and later at 90 days period's embryo skeletal muscle than that of 33 days, and showed a ubiquitously expression but with the highest abundance in kidney, lung and liver of an adult pig
brenda
additional information
-
the tissue-specific expression pattern of the CYP17 gene differs among species
brenda
additional information
-
tissue distribution
brenda
additional information
tissue distribution of the GSTA1 mRNA, overview
brenda
additional information
-
tissue distribution, overview
brenda
additional information
tissue expression pattern of GYS1, GYS1 is upregulated during porcine myogenic cell differentiation
brenda
additional information
tissue expression pattern of GYS2
brenda
additional information
tissue samples were collected from a total number of ten postpubertal crossbreed boars (nine German Landrace x Pietrain, one Large White) aged between 10 and 16 months. Immunolocalization study of SULT2A1. In epididymal samples, DHEA-ST activities are low in the head and in the proximal part of the body. In the distal body and tail, activities are in a similar range as observed in testicular samples, again with a considerable variability between individual animals and also between different segments of the organ
brenda
additional information
-
tissue-dependent enzyme expression in case of high-lysine diet, overview
brenda
additional information
-
tissue-specific functions, expression is developmentally regulated, detailed overview
brenda
additional information
-
traces of activity in liver, kidney, heart, brain, ovary and muscle
brenda
additional information
-
ubiquitous expression of CaMKII
brenda
additional information
-
variety of cultured cells and cell lines
brenda
additional information
-
wide tissue distribution
brenda
additional information
-
widely distributed in varying tissues
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.